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Abstract 
In recent years, microfluidics has been developed into a great tool for research and 
practical applications. Microfluidic systems are usually tens to hundreds of microns in 
size, enabling small volumes fluids handling. It has been applied in many disciplines, 
including chemistry, biology and medicine. Many advantages of microfluidics stem 
directly from the reduction in size and also the ability to integrate with microsensors and 
microactuators. The advantages include low reagent and sample volumes, compatibility 
with highly parallel experiments, ability to better simulate the natural physiology 
environment, ability to isolate factors of the cellular microenvironment and to spatially 
and temporally control individual experimental parameter, and low cost. 
This dissertation focuses on developing and optimizing appropriate microfluidics for in 
vitro cell analysis system with patient’s body fluids as input and information on patient’s 
health state as output. The steps include isolating cells of interest from patient’s sample, 
maintaining cell culture, differentiating cells and analyzing the molecules secreted by 
cells. This dissertation has achieved 1) enhancement of cell isolation efficiency of Jurkat 
cells by creating nanotopography in flatbed immunoaffinity microfluidics; 2) 
systematically developed maintenance and differentiation protocols in microfluidics for 
C17.2 NSCs; and 3) enhanced immunoaffinity detection of cell secretion molecules using 
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biotin as a model by introducing a combination of thermophoresis and convection 
induced by a mild temperature gradient in microfluidics.  
With successful demonstration and optimization of these microfluidic functions, it is 
hoped an easy, portable, low cost POC (point of care) microfluidic system can be 
developed and made available for health monitoring and/or disease diagnostics.  
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Chapter 1 
Introduction 
1.1 Introduction to In Vitro Cell Analysis 
Cells, as the basic structural, functional, and biological building block of a human body, 
carry tremendous information on the genetic make-up, the health and metabolic state of 
the individual it is taken from. In vivo cell analysis offers the advantage of direct 
observation of cells in their physiological environment, but can be very challenging to 
implement. On the other hand in vitro studies often need careful extrapolation of data to 
relate back to the state of the individual, but it has the advantage to isolate cells from their 
complex environment and study cellular responses to the individual components.    
In vitro cell analysis can also be done on the whole cell level, the organelle level and the 
molecular level. Analysis on the whole cell level monitors the physical, thermal, 
electrical, mechanical and optical properties of individual cells and whole cell activities 
such as ion currents in and out of the cell membrane, 1 cell migration, 2 and cell division. 
3 Organelles in each cell have vital functions, the analysis of which is also important. For 
example, energy production from mitochondria mediates apoptosis, 4 the proper function 
of Golgi complex and the caveolae membrane system are essential for endocytosis and 
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exocytosis, 5 and centrioles regulates spatial arrangement of the cellular structures and 
cell. 6 In vitro cell analysis can also be done on the molecular level. In this case, proteins, 
DNA, RNA and small molecules such as metabolites are isolated from the cells and 
detected biochemically: for example, co-immunoprecipitation, protein affinity 
purification, western blotting and two hybrid screening are methods often used in protein 
analysis; sequencing, hybridization and PCR (polymerase chain reaction) are commonly 
used for identification of nucleic acids; small molecules such sugar, ions, amino acids, 
peptides and superoxides are analyzed by corresponding assays centering around the 
analytes’ chemical and physical properties.   
The information from in vitro cell analysis not only provide fundamental understanding 
of cell biology, but also frequently used for disease prognosis, diagnosis and monitoring. 
For example, in vitro analysis to characterize T-helper type I cells and inflammatory 
macrophages in transgenic mice after experimental autoimmune encephalomyelitis 
revealed that the perceived central role for Interleukin -12 in autoimmune inflammation 
has been misinterpreted and that Interleukin -23, and not Interleukin -12, is the critical 
factor in this response. 7 In vitro analysis of peptide and peptide receptor expression of 
cells has been extensively documented and used as targets for cancer diagnostics over the 
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year. Examples include vascular somatostatin receptors for human colonic carcinomas; 
VIP/PACAP receptors for lung, stomach, colon, rectum, breast, prostate, pancreatic 
ducts, liver, and urinary bladder cancer; and Bombesin and GRP peptides for 
gastrointestinal tract, lung, prostate, and breast cancer. 8 After isolation from patient’s 
blood, T cells can be analyzed, activated and expanded in vitro before being re-injected 
into the patient. T cells with this type of in vitro treatment have potent antitumor effects 
and can establish memory in patients with advanced leukemia, indicating its potentially 
significant role in cancer therapeutics. 9  
1.2 Overview of Cell Isolation in Microfluidics 
Microfluidics is a powerful research tool with practical applications that emphasize the 
design of systems on micron scale in which small volumes of fluids will be handled. It 
has been applied in many disciplines, including chemistry, biology and medicine. 10–14 
Microfluidics offers many significant advantages in biological studies, stemming directly 
from the reduction in size. The advantages include low reagent and sample volumes, 
compatibility with highly parallel experiments, ability to better simulate the natural 
physiology environment, ability to isolate factors of the cellular microenvironment and to 
precisely control individual experimental parameter, and low cost.  
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Isolating cells of interest from biological sample is a major step for in vitro analysis. It 
can be achieved using physical or biochemical methods. Biochemical methods rely on 
surface protein expression while physical methods utilize properties such as cell size, 
density, and migration behavior. Biochemical methods are specific while physical 
methods are able to isolate cell populations to study without prior knowledge of the 
biomarkers. Traditional methods often have limitations that can be compensated by 
microfluidics: inadequate separation by gradient centrifugation can be eliminated by the 
precise streamline control offered by laminar flow in microfluidics; mixed cell population 
from adhesion separation can be further separated by fine tuning chemical and physical 
properties in microfluidics; expensive and labor-intensive methods, such as FACS 
(fluorescence-activated cell sorting) can incorporated into microfluidics that is low cost 
and requires minimal handling. Here an overview of current methods is provided.  
Biochemical methods: Immunoaffinity cell capture relies on antibody-antigen reaction 
between cellular surface and the capture substrate, which gives it the advantage of high 
specificity and high purity of cells captured. 15 The disadvantage is this capture process is 
often irreversible. The configurations frequently used in this methods are: flatbed and 
bead-based microfluidics. 
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Flatbed immunoaffinity capture: Cells can be isolated on flatbed microfluidic devices 
coated with the corresponding antibody for its expressed surface proteins. 16 Adding 
structural features including nanobeads, nanofibers and nanopillars can significantly 
increase the capture efficiency of the flatbed devices.17–19 
Bead-based immunoaffinity capture: Superparamagnetic polystyrene spherical beads 
coated with antibody can be mixed with cell samples in a solution. Once the beads adhere 
to the cells of interest, they can be pulled down by magnetic field while the unattached 
cells can be washed off. 20 
Physical methods: Cells can be isolated according to their physical properties such as 
size, dielectric property, their refractive index and their intrinsic magnetic properties. 
These methods have the advantages of minimal requirement on knowledge of biomarker 
expression and the ability to release cells reversibly for further analysis while bare the 
disadvantage of non-specificity.  
Size-based capture: Size-based cell capture isolates cells according to their physical 
dimension, which gives it the disadvantage of nonspecificity, but it can be useful in 
isolating uncharacterized cells with no prior knowledge of their biochemical 
characteristics. This is particularly useful in the case of blood cell isolation, given the size 
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of white blood cells, red blood cells and plasma content are drastically different. A 
microfluidics with a continuous flow diffusive filter has been designed for depletion of 
leukocytes from blood with >97% leukapheresis rate, providing a cheaper faster 
alternative to centrifugation and fiber mesh filtration. 21 
Flow-based capture: Flow-based cell capture takes advantage of the low Reynolds 
number fluid flow associated with the imposition of certain geometries or parallel fluid 
flows of different flow rates to passively sort or segregate target cells. 22 This method 
sorts cells by their physical dimension and is non-specific. For example, spiral 
microfluidic devices can be used to sort cells according to their sizes. The inertial forces 
coupled with the Dean rotational force due to the curvilinear microchannel geometry 
cause cells to occupy a single equilibrium position near the inner microchannel wall. The 
position at which cells equilibrate is dependent on the ratio of the inertial lift to Dean 
drag forces, therefore cells of different sizes will accumulate at specific locations at the 
outlet. 23  
Cell sorting based on other properties of cells can also be achieved, such as 
Dielectrophoresis-based isolation, 24 optical tweezer isolation 25 and native magnetic 
properties-based sorting. 26 These methods do not often require immune labeling of the 
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cells, but rely on physical properties of cells such as their dielectric property when 
subjected to a non-uniform electric field, their refractive index and their intrinsic 
magnetic properties.  
1.3 Overview of Cell Culture and Cell Differentiation in Microfluidics  
Traditional cell culture and cell differentiation are often carried out in flat-surface petri 
dishes or cell culture flasks that suffer from non-uniformity of surface properties, 
inhomogeneity of chemical compositions in media, lack of 3D structures that mimic the 
physiological environment and lack of temporal control. Microfluidics are used to 
provide more precise spatial and temporal control of the physical and biochemical 
environments around cells. The resulting cell responses shed light about fundamental cell 
biology in healthy and pathological states. On the physical control front, shear stress, 
tensile stress, substrate stiffness, and fiber alignment are all parameters of interest. For 
example, microfluidic devices with a low shear rate cyclic flow that mimics the 
mechanical, structural, absorptive, and transport properties of the human gut has been 
developed for transport, absorption, and toxicity studies, giving great value for drug 
testing as well as development of novel intestinal disease model. 27 Computer integrated 
air-liquid two-phase microfluidic systems have been developed to enable on-chip 
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engineering of human airway epithelia and precise reproduction of physiologic or 
pathologic liquid plug flows found in the respiratory system to study cellular-level lung 
injury under flow conditions that cause symptoms characteristic of a wide range of 
pulmonary diseases. 28 Other than shear stress, substrate stiffness is also an effective tool 
for regulating cell behaviors such as locomotion, proliferation and differentiation. 
Microfluidics with polydimethylsiloxane (PDMS) stiffness gradients have been created to 
study osteogenic differentiation of rat mesenchymal stem cells to develop better implant 
materials and tissue engineering scaffolds. 29 
Chemical environment also plays a significant role in regulating biological and 
pathological processes, such as chemotaxis and embryogenesis can be easily manipulated 
in microfluidics to study cell growth, differentiation, migration, and apoptosis. 30 
Microfluidics with stable and well-defined conflicting gradients of IL-8 and LTB4 have 
been used to staudy neutrophil chemotaxis. 31 Multiplexing of simultaneous chemical 
stimulation can be readily achieved using microfluidics: a continuous gradient of a 
growth factor (GF) mixture containing epidermal growth factor (EGF), fibroblast growth 
factor 2 (FGF2) and platelet-derived growth factor (PDGF) has been generated by 
continuous flow in microfluidics to study the differentiation of human NSCs (hNSCs) 
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from the developing cerebral cortex into astrocytes offering guidance for a wide range of 
basic and applied studies on human NSCs. 32 Temporal chemical gradient can also be 
easily manipulated in microfluidics: a microfluidic device that mimics the exponential 
clearance curve of chemicals in the human body has been used to study the toxicant 
response of fibroblast cells. 33 
While microfluidic cell culture offers advantages such as flexibility in the design of 
microfluidic devices, the ability to more closely mimic a cell's natural microenvironment, 
parallelization, on-chip analysis or direct coupling to downstream analytical chemistry 
platforms, low reagent consumption and low cost, transferring our knowledge of 
macroscopic cell culture to microfluidic cell culture requires careful examination. 
Changes in device material, surface coating, and cell number per unit surface area or per 
unit media volume may all affect the outcome of otherwise standard protocols. 34 
Parameters of long standing research interest include, but not limited to surface treatment 
(UV, oxygen plasma), 35 surface cell adhesion molecule coating, 36 oxygen transport, 34 
osmolarity, 37 pH, 37 nutrient consumption and medium turnover rate. 38,39 Current 
research methods often involve adjusting the culture parameters in microfluidic and 
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compare cellular behavior as such migration, viability, metabolic state and toxicity status 
to those in macroscopic culture. 34 
Stem cell differentiation is essential for the development of any organism. It also occurs 
in adulthood as adult stem cells divide and create fully differentiated daughter cells 
during tissue repair and during normal cell turnover. It is an area of active research, in 
which microfluidics finds itself particularly useful due to its precise control of the 
microenvironment.  
Stem cell differentiation can be initiated by many physical and chemical compositions of 
the microenvironment, including shear stress, surface structure, growth factor 
concentration and exposure to cytokine, all of which are controllable in microfluidic 
devices with spatial and temporal resolution mimicking in vivo environment. Kapur et al. 
analyzed the role of several signaling pathways in the fluid flow shear stress-induced 
proliferation and differentiation of normal human osteoblasts. 40 Chung et al. cultured 
human neural stem cells from the developing cerebral cortex in a microfluidic device 
constantly generating a gradient of a growth factor mixture containing epidermal growth 
factor (EGF), fibroblast growth factor 2 (FGF2) and platelet-derived growth factor 
(PDGF) to show graded differentiation results proportional to growth factor 
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concentration.32 Park et al. cultured neural progenitors derived from human embryonic 
stem cells in a microfluidic system generating continuous cytokine gradients (sonic 
hedgehog, fibroblast growth factor 8, and bone morphogenetic protein 4) to show 
opposing effects of agonist (sonic hedgehog) and antagonist (bone morphogenetic protein 
4) on neural differentiation.41 Yim et al. used both retinoic acid and PDMS 
nanotypography to study the differentiation of human mesenchymal stem cells into neural 
lineage. 42 They found a combination of nanotopography and biochemical cues such as 
retinoic acid further enhanced the upregulation of neural marker expressions, but 
nanotopography showed a stronger effect compared to retinoic acid alone on unpatterned 
surface. 42 Yang et al. cultured C17.2 mouse neural stem cells on electrospinned 
nano/micro scale poly(l-lactic acid) aligned fibers. 43 They were able to align the 
direction of cell elongation and its neurite outgrowth to the direction of PLLA fibers. 
They also found out the rate of neural differentiation was higher for PLLA nanofibers 
than that of micro fibers and it was independent of the fiber alignment. 43 
1.4 Detection of Cell Secretion  
Cells secret many protein molecules including regulatory molecules such as hormones 
and neurotransmitters, digestive enzymes, antibodies, mucus and structural proteins such 
14 
 
as collagen. The secretome profile is often assayed to interrogate cell function. Popular 
detection methods based on the signal they analyze are introduced here. 
Fluorescence detection: Fluorescent material emits light upon absorbing light of a shorter 
wavelength and higher energy. The major advantage of fluorescence detection is 
simplicity and high sensitivity, while potential pH sensitivity and susceptibility to 
photobleaching over time are their disadvantages. 44 Adapting traditional fluorescence 
detection methods such as ELISA (enzyme-linked immunosorbent assay) and FACS 
(fluorescence-activated cell sorting) in microfluidics help to enhance their capability by 
lowering sample volume requirement, enhancing detection sensitivity, eliminating 
expensive equipment and lengthy procedures, and enabling real-time detection. It has 
been shown the amount of fluorescence protein expression in single E. coli cells can be 
quantitatively measured using droplet microfluidics. 45 With the development of brighter 
and more stable fluorescent labeling such as quantum dots and more sophisticated 
method such as FRET (Förster resonance energy transfer), even real-time analysis of 
single molecule can be realized. 46 
Chemiluminescence detection: This method relies on the emission of energy in the form 
of light (with limited emission of heat) as the result of a chemical reaction. It requires no 
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excitation instrumentation, even though emission is generally low. 44 Traditional methods 
suffer from poor detection sensitivity due to low emission; on the other hand, 
microfluidics offers a more stable environment and therefore a lower background noise, 
which helps to improve the detection sensitivity. 47 Applications include detection of 
human serum albumin or immunosuppressive acidic protein as a cancer marker in human 
serum for cancer diagnostics, 48 allergen screening and near-patient diagnostic 
immunoassays. 49 
Surface plasmon resonance (SPR): SPR is capable of real-time highly sensitive label-free 
analysis of mass change in close proximity. It relies on the change in resonant oscillation 
of conduction electrons brought by mass change at the interface between a negative and 
positive permittivity material stimulated by incident light. Due to the high sensitivity and 
close proximity of SPR, integration with microfluidics greatly enhances its performance 
by providing a precisely controlled environment with minimal fluctuations. Performance 
immunoassays include IgG, 50 cardiac marker B-type natriuretic peptide, 51 porcine 
circovirus type 2 52 and interleukin-8 analysis, 53 just to name a few.  
Resonance-frequency mass sensing: Cantilevers and quartz crystal micro-balance are two 
techniques relying on a change in resonant frequency to detect a mass change. It offers 
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high sensitivity, high specificity and simplicity to operate. However, traditional bulk 
methods are difficult to implement in fluidics due to damping, viscosity effects and 
thermal fluctuations, 44 which can be minimized in microfluidics.    
Conductance detection: Nanowires can be used to detect molecular binding on its surface 
that changes the wire’s conductance. The small dimension of this method limits its use to 
small scale studies such as in microfluidic. They offer the advantage of low volumes, 
real-time sensing, a very high sensitivity and great multiplexing capability. 54 However, 
their complicated fabrication and patterning procedures and requirement for electronic 
components makes them a rather expensive choice.  
Label-free detection methods capable of direct quantification of the analyte without 
labels eliminates the need for tags, dyes or specialized reagents or engineered cells, 
reducing the resources and procedures required for assay development and minimizing 
liabilities created by the use of labels. Primary labels can be added to the analyte to assist 
detection. Adding label offers the advantages of high sensitity, specificity and ability to 
simultaneously analyze multiple cellular properties by different tags. Commonly used 
labels can be fluorescent, colorimetric or radioactive. A signal amplification step can be 
added to the labeling process by introducing a sandwiched assay: primary labels specific 
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to the analyte are added to surface immobilized analyte of unknown concentration, then a 
secondary label that detects the primary label is used to quantify the amount of primary 
tags which in turn quantifies the amount of analyte. The secondary labels can be tagged 
with fluorescence, colors or radioactive isotopes themselves or they can trigger reactions 
that produce signals such as chemiluminescence, wavelength shift or color intensity 
change. The advantages of using a sandwiched assay are ability to simultaneously detect 
different analyte in multiple-target assays and increased detection sensitivity from signal 
amplification. A summary of detection methods and the number of labels they often use 
is listed here. 
Table 1.1: Popular detection methods and the number of labels often used 
Popular detection methods  Number of labels often used 
Fluorescence detection 1, 2 
Chemiluminescence detection 0, 1, 2 
Surface plasmon resonance 0, 1 
Resonance-frequency mass sensing 0, 1 
Conductance detection 0 
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1.5 Summary 
In this dissertation, research will be conducted in areas of in vitro isolation, culture, 
differentiation of cells and biomolecule detection in microfluidics. The aims for each 
chapter are 1) providing background in each area; 2) enhancing cell isolation efficiency 
by creating nanotopography in flatbed immunoaffinity microfluidics using Jurkat model 
system; 3) systematically developing maintenance and differentiation protocols in 
microfluidics using C17.2 NSCs; 4) enhancing immunoaffinity detection by introducing a 
mild temperature gradient directly above the affinity substrate and 5) providing a 
summary of goals achieved and future outlooks.   
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Chapter 2 
Jurkat Cell Capture in Microfluidics with 
Surface Nanotopography 55 
2.1 Movitation 
Microfluidic cell isolation devices have recently found applications in tissue engineering, 
56,57 clinical diagnosis, 58,59 and fundamental cell biology. 60,61 Immunoaffinity isolation 
based on specific cell surface markers attracts special attention due to its capability to 
distinguish cell types of similar physical properties in complex samples, for example 
human blood. 58,62,63 Its ease of use makes it a good candidate for point of care settings.  
Immunoaffinity cell capture generally takes one of two forms: target cells attach to either 
suspended magnetic beads, 64 or interior surfaces of a microfluidic chip. 65 Cell-antibody 
interactions are more accurately controlled in the latter strategy and as such it yields 
higher capture efficiency and purity of target cells. 58 Toner’s group has designed 
immunoaffinity microfluidics for reliable isolation of circulating cells at concentrations 
as low as 5 cells/mL from whole blood with average purity higher than 50%, 58,63 which 
exceeds the performance of commercially available magnetic bead-based assays. These 
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microchips have been shown to diagnose cancer, 58 infection, 66 and inflammatory 
diseases 62 with minimal sample handling.  
To enhance cell interactions with antibody-functionalized device walls, several groups 
have employed capture beds with nanotopography. Wang et al. fabricated nanopillars to 
enhance contact frequency and duration of circulating tumor cells with functionalized 
substrates and increased capture yield by greater than 40%. 17 The King group deposited 
nanobeads and nanofibers in capillary channels to isolate stem cells and tumor cells. 18,19  
Capture yield increased by up to 100% in deposited versus smooth capillaries. While 
these studies suggest a positive effect of nanotopography on cell capture, nanopatterns 
studied contain either a single geometry or random structures that do not elucidate 
detailed relations between the two. In a separate study, Tuttle et al. immobilized 
antibodies on surface-bound nanobeads 40 to 860nm in diameter and tested their 
functionality by capturing antigen coated fluorescent microspheres. 67 Specific capture 
increased continuously with the nanobead size. The results were suggested to stem from 
greater amounts of immobilized antibodies and an enhancement of collective antibody 
functionality on rough surfaces. Additionally, the Santore group investigated affinity 
between microbeads and patched charge capture surfaces with varying overall charge 
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density and patch size. 68–70 Although these studies explored a variety of nanostructured 
geometries, the interaction of microbeads with rough or patterned surfaces may not 
translate fully to that of the cells. Built on these previous findings, in this study we 
carefully controlled surface nanotopography over a greater range than that previously 
explored and studied its influence on immunoaffinity capture of lymphocytes. 
To create surfaces with reproducible and uniform nanotopography we modified smooth 
glass substrates by the addition of a monolayer of close-packed, uniform-sized, silica 
nano-beads 100 to 1150 nm in diameter. These surfaces were incorporated as the base of 
microfluidic channels then functionalized with CD4 antibodies in order to capture CD4+ 
cells from human lymphocyte culture under continuous flow. In addition to depositing 
nanobeads with varying diameters, numerous flow rates and altered cell mechanical 
properties were evaluated in order to explore the mechanisms behind cell interactions 
with rough functionalized substrates.  
2.2 Materials and Methods  
2.2.1 Preparation of Silica Nanobeads 
The particles used in this studying have diameters between 100 and 1150 nm to cover the 
size range reported in the literature for cell capture enhancement. Silica particles within 
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this size range also forms stable suspensions compatible with the convective deposition 
process. We refer to the spheres used in this study as nanoparticles in this paper, and they 
are sometimes also referred to as colloidal particles and microspheres in the literature.  
Nanospheres 100 nm, 460 nm, and 490 nm in diameter were prepared through hydrolysis 
of TEOS in 200 proof ethanol with 0.2 M TEOS, 17.0 M DI water, and 0.2, 1.2, and 1.6 
M NH3 respectively. 71 309 nm particles were prepared through similar hydrolysis of 
TEOS in 190 proof ethanol with 0.04 M TEOS and 2.45 M NH3. 72 319 nm particles were 
prepared with 200 proof EtOH with 0.13 M TEOS, 18.9 M DI H2O, and 1.6 M NH3. 72 
Particles 407 nm in diameter were prepared in 190 proof ethanol with 0.29 M TEOS, 6 M 
DI water, and 1.9 M NH3. 73 In all cases NH4OH, DI water (when applicable) and ethanol 
were mixed initially. TEOS and ethanol, also pre-mixed, were added to the ammonia 
solution to start the particle synthesis reaction. Note that DI H2O was not a unique 
component in some recipes—NH4OH is NH3 in H2O (29% NH3 on average and used as 
received). 
While the upper limit of synthesizable particles through batch reactions is around 500 
nm, larger particles were made by a core-shell type approach. The first method was a 
continuous core-shell synthesis process in which seeds were first prepared by the addition 
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of 1 mL TEOS and 4 mL 200 proof ethanol to 46 mL 200 proof ethanol and 9.0 mL 
NH4OH (29%). After two hours an additional 5 mL TEOS/20 mL ethanol solution was 
fed continuously at 0.1 ml/min to yield 700nm SiO2 microspheres. 72 In a separate semi-
batch process, 500 nm seeds were grown to 928 and 1150 nm in diameters. Here 
hydrolysis similar to the batch processes presented earlier was carried out as 4.25 g 
TEOS ([TEOS] = 0.2 M) and 35.88 g 200 proof EtOH were added to 13.63 g EtOH, 
24.88 g DI H2O ([DI H2O] = 17.0 M), 7.03 g NH4OH ([NH3] = 1.2 M), and 300 µl 
500nm SiO2/EtOH (46% v/v). 71 This yielded 928 nm SiO2 microspheres. An additional 
4.25 g TEOS in 35.88 g EtOH added one day later formed an additional shell atop the 
928 nm SiO2 microspheres and brought the final diameter to 1150 nm.  
All experiments were carried out at room temperature in sealed vessels under moderate 
stirring. Post-synthesis, the particles were centrifuged and washed with ethanol and DI 
H2O a minimum of three times each. Centrifugation times were based on the terminal 
particle settling velocity in order to remove both excess reagents and any smaller 
secondary constituents formed as byproducts in our reactions. For deposition, particles 
were suspended in DI H2O and brought to an appropriate volume fraction based on their 
size (see Table 2.1). Note that changes in chemical suppliers and product lots from those 
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suppliers yielded small size variations in particles synthesized. However, with consistent 
reagents particle growth was highly linear and scalable.   
Table 2.1: Concentration and optimal deposition speed of nanobeads used in this study 
Size of silica beads (±1 SD) Concentration (v/v in DI-water) Optimal speed 
100 ± 10nm 12.84% 3 μm/s 
309 ± 30nm 12.84% 6 μm/s 
319 ± 17nm 11.80% 33 μm/s 
407 ± 23nm 10.84% 10 μm/s 
460 ± 20nm 26.50% 21 μm/s 
490 ± 20nm 25.90% 58 μm/s 
700 ± 24nm 32.40% 17 μm/s 
928 ± 16nm 15.20% 42 μm/s 
1150 ± 24nm 12.50% 67 μm/s 
 
2.2.2 Preparation of Close-Packed Silica-Nanobead Substrates 
Close-packed silica-nanobead substrates were prepared through convective deposition 
following the method reported by Kumnorkaew. 74 Plain glass microslides were used as 
deposition blades and substrates. Deposition substrates were cleaned in piranha solution 
(sulfuric acid and hydrogen peroxide at 3:1 volume ratio) for over 1 hour, thoroughly 
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rinsed with deionized (DI) water and then stored in DI water until needed. The ends of 
the deposition blades were hydrophobically treated by coating with parafilm. 
A schematic of the convective deposition setup is shown in Figure 2.1. The deposition 
blade angle was positioned at 45 degrees above the substrate as calibrated with a digital 
camera. Ten microliters of SiO2/DI H2O suspension was injected between the substrate 
and blade with a micropipette. The substrate was then linearly translated at the 
appropriate speed, as governed by specific suspension evaporative flux, for monolayer 
deposition. 
 
Figure 2.1: Experimental setup for nanobead deposition. Silica nanobeads from 100 to 
1150 nm in diameter, synthesized through TEOS hydrolysis, were deposited into close-
packed monolayers to control substrate nanotopography. A linear motor was used to 
translate the substrate. The hydrophobically-treated glass blade was positioned at a 45 
degree angle with respect to the substrate and 10µL SiO2 nanobead/DI H2O suspension 
was pipetted into the space between. The beads packed into a 2D crystals as the bulk 
suspension dragged across the glass substrate and the solvent (DI H2O) evaporated. 
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Reprinted with permission from Effect of Surface Nanotopography on Immunoaffinity 
Cell Capture in Microfluidic Devices. 55 Copyright (2011) American Chemical Society. 
Substrates covered with a smooth layer of TEOS were prepared as a control with 
identical surface chemistry but minimal roughness (root mean squared surface roughness 
< 2.0 nm). Clean glass sides (root mean squared surface roughness < 3.0 nm) were 
soaked in an ethanol solution with TEOS for 15 minutes. Subsequently the slides were 
thoroughly washed with ethanol and blown dry with nitrogen. 
2.2.3 Device Preparation 
The nanoparticle-coated substrates were patterned in a 3 mm x 3 mm square region for 
cell capture. Beads outside the square capture region were removed with a clean room 
adhesive tape. A microchannel was then bonded atop the substrate to enclose both the 
nanosphere pattern and a bare glass control region. 
Polydimethylsiloxane (PDMS) microchannels were prepared by pouring a 10:1 mixture 
of silicone elastomer base and silicone elastomer curing agent onto an SU8 mold 
patterned on a silicon wafer. Simple straight channels with dimensions 14 mm x 4 mm x 
50 µm (L x W x H) were fabricated. PDMS was degassed and cured at 70 °C and the 
microdevices were cut out. Fluid inlets and outlets were drilled using a syringe needle. 
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Nanobead-deposited substrates and microchannels were activated by oxygen plasma, then 
carefully aligned and heated for 5-10 minutes at 70 °C to produce permanent bonding. An 
image of a typical assembled device is presented in Figure 2.2.  
After assembly the interior walls of the device, including the nanobead-deposited area 
and a bare glass region, were functionalized using a previously published method. 66 A 
4% (v/v) solution of 3-mercaptopropyl trimethoxysilane in ethanol was injected into the 
device and allowed to incubate for 1hr at room temperature. Next the device was 
incubated with 0.01 μmol/ml GMBS in ethanol for 1 hour at room temperature. 
NeutrAvidin was then immobilized to GMBS by incubating chamber surfaces with a 10 
μg/ml NeutrAvidin solution in PBS (phosphate buffered saline) for at least 1 hour at 4 °C. 
Finally, 10 μg/ml of biotinylated antibody solution in PBS containing 1% (w/v) BSA was 
injected to react at room temperature for at least 15 minutes before cell capture 
experiments were performed. 
2.2.4 Cell Culture and Live Cell Capture 
Jurkat cells (human lymphocytes) were maintained following the ATCC protocol at a cell 
concentration of 105 cells/mL to 106 cells/mL using RPMI-1640 media supplemented 
with 10%(v/v) FBS and 1%(v/v) pen-strep. Cells were centrifuged and resuspended at 
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106 cells/mL in culture media prior to cell capture experiments. Cell suspension was 
delivered into the device using a syringe pump at constant flow rates of 2μL/min, 
5μL/min, or 8μL/min for 15 minutes. These flow rates are within the optimal window for 
CD4+ T cell capture, as found in prior work. 66 The sample injection time was chosen to 
ensure that target cells were not depleted from the suspension prior to reaching the 
downstream capture area. The numbers of cells captured in the patterned and bare glass 
regions in a given channel (Figure 2.2, Device 1) were counted using a bright field 
microscope. The counts on bare glass served as an internal control to account for slight 
batch to batch variations in testing conditions.  
As bare glass slides have slightly different chemistry versus silica beads synthesized by 
TEOS hydrolysis, 75 we also prepared smooth TEOS coatings on glass substrates as 
samples with minimal roughness (Device 2). The normalized cell capture efficiency, η,  
were obtained by taking the ratio of cell counts on silica beads versus that on smooth 
TEOS coatings using the following formula: 
𝜂(𝑅) =
𝑛𝑛𝑏(𝐷)
𝑛𝑏𝑔1
×
𝑛𝑏𝑔2
𝑛𝑇𝐸𝑂𝑆
 
where nnb(D) is the number of cells captured on nanobeads in the patterned region in 
Device 1, nbg1 and nbg2 are counts of cells captured on bare glass region within Device 1 
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and Device 2 respectively, and nTEOS is the cell count from smooth TEOS-treated regions 
in Device 2. 
2.2.5 Capture of Fixed Cells 
In order to test cells with altered mechanical properties, cells were centrifuged and re-
suspended in 1% glutaraldehyde in PBS (v/v) for 30 min. This glutaraldehyde fixation 
process crosslinks proteins in the cell membrane and thus increases its modulus. The 
fixed cells were centrifuged, washed in PBS, and then resuspended in culture media at a 
concentration of 106 cells/mL for capture. In a separate experiment, Jurkat cells were 
fixed with 1% glutaraldehyde in PBS for 30 min and then stained with Hoechst 33258 
(0.5mg/ml in PBS) for 10min. After rinsing, the fixed and stained cells were mixed with 
untreated live Jurkat cells at a 1:1 ratio in culture media with a total cell concentration of 
106 cells/mL. This cell mixture was also used for cell capture at selected bead size and 
flow rates. To test if glutaraldehyde fixation affected antibody-antigen binding, the same 
cell mixture was used for capture experiments in microchannels bonded to antibody 
functionalized bare glass. The number of each cell type captured within the same imaging 
areas was counted and the two quantities compared.    
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Figure 2.2: The cell capture microchip used in this study. (A) Photograph of a 
microchannel formed by oxygen plasma activation and bonding of PDMS, with an 
imprinted microchannel, to the glass substrate, with nanoparticle-patterned and bare glass 
regions. The deposited nanobead pattern (cloudy region in the black square) and a control 
region of bare glass (red dashed square) were enclosed in the same microchannel. The 
entire substrate was further functionalized with a CD4 antibody for CD4+ T cell capture 
from Jurkat cell cultures. (B) A schematic showing nanobead-covered and control glass 
regions within the same channel. Reprinted with permission from Effect of Surface 
Nanotopography on Immunoaffinity Cell Capture in Microfluidic Devices. 55 Copyright 
(2011) American Chemical Society. 
2.2.6 COMSOL Simulation 
Flow above a layer of close-packed beads was simulated in COMSOL Multiphysics 
4.0(COMSOL Inc., Burlington, MA). Assuming a 2D crystal structure, we carry out the 
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simulation within a periodic cell of a hexagonal array of 1 µm spheres. A constant 
velocity is imposed on the layer three particle diameters from the substrate in order to 
investigate the near-field disturbance. The fluid is Newtonian and a volumetric flow rate 
of 2 µL/min renders a very small Reynold’s number (Re << 1). Therefore flow near the 
walls is self-similar and scales with bead size. 
2.2.7 Imaging and Statistical Analysis 
Antibody immobilized cells on smooth glass substrate were imaged using a confocal laser 
scanning microscope (Visitech international, model VTeye). The cells were stained by 
0.16 mM Rhodamine B in the normal culture media for 10 minutes and imaged without 
further washing. The z-stack images were taken using 100x magnification and expressed 
as a 3D image with ImageJ.  
AFM measurements were carried out on a Nanoscale V AFM in tapping mode to 
characterize 100, 490, and 1150 nm individual particle roughnesses as well as the 
roughness of TEOS-coated and bare glass. Gwyddion was used for data analysis and 
visualization. Individual particle roughness values are documented as Root Mean 
Squared (RMS) Roughness. SEM measurements were performed on all nanobead 
depositions with Iridium coating using a Hitachi 4300 instrument (Japan). The diameter 
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and packing of nanobeads are documented in the images.   
All cell captured experiments were repeated in at least 5 independent devices, except for 
Figure 7, where the experiments were repeated in at least 3 independent devices. The data 
were analyzed using two-tailed t tests. Two p values were calculated for the data points 
presented in Figure 2.4, Figure 2.6 and Figure 2.7: one from comparing the cell capture 
on nanobead surfaces to that on TEOS under the same flow rate; the other by comparing 
the cell capture on a particular sized nanobead surface to its neighboring data point of a 
smaller nanobead diameter. When the p value between two data points was less than 0.1, 
their difference was considered statistically significant.  
2.3 Results and Discussions 
2.3.1 Silica Bead Depositions  
In this work close-packed silica-nanobead depositions were used to accurately control 
surface nano-topography in micorchannels over a broad range of experimental 
conditions. The influences of these layers on immunoaffinity cell isolation were studied. 
Since the particle surfaces, glass and TEOS directly treated glass slides are all very 
smooth with a root mean squared (RMS) roughness less than a few nanometers by AFM 
measurements, the surface roughness is mainly controlled by the radius of the particles. 
33 
 
The arithmetic surface roughness is defined by the following equation: 76  
𝑅𝑎 = √
1
𝑛
∑ 𝑌𝑖2
𝑖=𝑛
𝑖=1
 
Where Ra is the arithmetic surface roughness, n is the number of points along the top 
surfaces, and Yi is the vertical distance of the ith point from the mean surface height. For 
close-packed nanobead depositions, Ra can be further expressed as:  
𝑅𝑎 = √
1
𝑛
∑ (∫ 𝑅𝑐𝑜𝑠𝜃)
𝜃=𝜋/2
𝜃=0
2
𝑖=𝑛
𝑖=1  = radius of nanobeads 
We used convective deposition to create ordered nanobead monolayers atop glass 
substrates. While humidity, particle size, suspension volume fraction, substrate speed, 
and blade angle were all found to influence the packing quality of nanoparticles, 74 
preliminary work showed that solely varying deposition speed was sufficient to obtain 
hexagonally close-packed nanobead arrays. The beads were deposited from suspensions 
at 10.84%-32.40% volume fractions in water. Close-packed morphologies of the 
deposited layers were verified with scanning electron microscopy (SEM). Optimized 
deposition speeds for each particle size are summarized in Table 2.1. The corresponding 
nanoparticle layer morphologies are presented in Figure 2.3. The size range of nanobeads 
was chosen because they are on the same order of magnitude as the size of nano-
structures on cell membrane, which was suggested to enhance cell capture in previous 
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work. 17  
Even though the size of the nanobeads used in our study covers a broad range, the 
increased surface area for cell capture actually remains the same for all sizes and is 
independent of nanobead diameter as long as the beads have similar packing structure. 
This can be shown by the following calculation: 
Total area for cell capture after nanobead depositon = 
𝐴𝑓
𝜋𝑅2
2𝜋𝑅2= 
𝐴𝜋
√3
 
Where A is the surface area on the substrate covered by beads, f is the fraction of the 
substrate covered by beads, which is 
𝜋
2√3
 for 2D hexagonal close-packing, and R is the 
radius of the nanobead. The capture surface area on the nanobead-covered substrates is 
~1.8 times of that on a flat substrate, such as TEOS.  
 
Figure 2.3: Scanning electron microscope images of close-packed particle arrays with 
diameters of (B) 100 nm, (C) 309 nm, (D) 319 nm, (E) 407 nm, (F) 460 nm, (G) 490 nm, 
(H) 700 nm, (I) 928 nm and (J) 1150 nm. Image (A) shows a glass surface coated with a 
smooth layer of TEOS. All scale bars = 500nm. Standard deviations of the particle sizes 
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are summarized in Table 2.1. Reprinted with permission from Effect of Surface 
Nanotopography on Immunoaffinity Cell Capture in Microfluidic Devices. 55 Copyright 
(2011) American Chemical Society.  
2.3.2 Live Cell Capture on Silica-Nanobead Substrates 
Next the silica nanobead deposited substrates were enclosed within PDMS microchannels 
and functionalized with CD4 antibodies to capture CD4+ T cells under continuous flow. 
Three different flow rates, 2, 5 and 8 l/min, covering the optimal range for CD4+ T cell 
capture, were evaluated. 66 Jurkat cells, a human T lymphocyte cell line, were used for 
capture experiments and 23.8% of the cells were found to be CD4+ as by flow cytometry 
analysis. The total number of captured cells was enumerated as specific capture since the 
surface chemistry has been shown to yield greater than 95% purity. 66 The number of 
cells captured on the silica nanobead deposition was normalized to that on a 
functionalized smooth TEOS surface (approximating a continuous array of infinitely 
small silica beads) using the formula shown in the Experimental Section. This 
normalization minimizes the effects of any run-to-run non-uniformity and allows direct 
comparison of capture efficiencies with different surface nanotopography.  
Figure 2.4A shows a typical image of cells captured on the nanopatterned surface. 
36 
 
Typically, ~50 cells/mm2 were captured with 15 minutes sample delivery. Reversing the 
flow direction did not affect capture results, indicating that the capture difference in the 
up- and downstream regions was not due to target cell depletion. Figures 2.4B-2.4D 
show that nanopatterned surfaces generally improve capture efficiency versus smooth 
substrates, however, the two do not have a monotonic relationship. Statistically 
significant data sets are highlighted. Data points with * have a statistically different cell 
capture compared with the capture on TEOS under the same flow rate with p < 0.1. Data 
points in red circles have statistically different cell capture as compared to their preceding 
neighbor (neighboring data set of a smaller nanobead size) with p < 0.1. The cell capture 
efficiency profile strongly depends on flow rate. At 2 μl/min (wall shear stress of 5.5x10-
5N/m2) the capture efficiency increases nearly continuously from 100%, the 
normalization value on smooth TEOS (control) to 160% on roughened surfaces with the 
largest beads (1150nm). Interestingly the capture efficiency dips on surfaces coated with 
700 nm particles to the level of the control, smooth TEOS, samples. At 5μl/min (wall 
shear stress of 1.385x10-4N/m2) the cell capture efficiency first climbs with increased 
surface roughness, and gradually decreases as bead size further increases. An outlier to 
this trend is a significant decrease in capture efficiency with a 407 nm bead-patterned 
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substrate—this yielded only 60% capture as compared with the smooth TEOS surface. 
The 8 μl/min (wall shear stress of 2.215x10-4N/m2) trend follows the 5 μl/min capture 
profile. The cell capture efficiency nearly doubles for the smallest deposited particles 
then decreases with nanobeads greater than 700 nm in diameter. The capture profile 
shows two significant dips at 407 and 490 nm where the capture efficiencies are 
comparable to those on smooth surfaces. Thus cell capture on rough surfaces is not only 
dependent on surface topography but also on wall shear stress.  
The complex capture profiles are not expected to result from increased surface area after 
nanobead deposition. The difference between TEOS and nanobead surfaces are likely due 
to surface area increase (an 80% increase in surface area with nanobead deposition), but 
difference on the various beads are not (surface area is independent of nanobead size 
under hexagonal close-packing). It is also unlikely a result of surface chemistry or 
antibody density as different-sized beads were synthesized under the same TEOS 
hydrolysis reaction with only reaction time and reagent concentration varying. In 
addition, under static incubation cell capture was comparable on patterned substrates of 
various bead sizes and smooth TEOS (data not shown); this also suggests comparable 
surface chemistry among the different roughness conditions.  
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Figure 2.4: (A) Bright field image showing CD4+ cells captured on a surface patterned 
with 928nm beads under 5 μl/min sample flow (scale bar = 50μm). (B)-(D) Normalized 
capture efficiency on nanobead-covered substrates. Cell suspension flow rates were (B) 2 
μl/min, (C) 5 μl/min, and (D) 8 μl/min. The numbers of cells captured on the silica 
nanobead surfaces were normalized to those on smooth TEOS-coated surfaces 
(approximating a particle layer of infinitely small particles) for direct comparison of 
capture efficiencies. Error bars show one standard deviation in 5-10 trials. Data points 
labeled with * have a statistically different cell capture compared with the capture on 
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TEOS with p < 0.1, while data points in red circles have a statically different cell capture 
compared to its preceding neighbor (neighboring data set of a smaller nanobead size) 
with p < 0.1. Reprinted with permission from Effect of Surface Nanotopography on 
Immunoaffinity Cell Capture in Microfluidic Devices. 55 Copyright (2011) American 
Chemical Society. 
Cell capture on rough surfaces under continuous flow could be influenced by cell 
movement near substrates, shear induced deformation, and increased capture surface area 
as proposed previously. Inertial migration of flowing cells, however, should not be a 
main contributor to the complex capture patterns as the Reynold’s number Re is much 
smaller than 1 under all flow conditions. Numerical simulation (Figure 2.5) confirms that 
the flow is essentially undisturbed at heights roughly two bead-diameter from the bottom 
substrate. Even the largest particles deposited here (1150 nm in diameter) are much 
smaller than Jurkat cells (7-20µm in diameter 77) captured. As a result, cell movement 
under these near Stokes flow conditions should not significantly undulate with surface 
topography or lead to any abrupt changes to cell migration at the dipping points in the 
capture efficiency curves. In addition, in these dilute cellular suspensions, multibody 
hydrodynamic interactions are also minimal. The only nonlinear behavior in this near-
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wall interaction is the elasticity of the cellular membrane. We thus hypothesize that 
mechanical deformation of cells on the cellular and sub-cellular level is the key factor 
contributing to the complex capture profiles observed.  
 
Figure 2.5: (A) Fluid velocity profile at a cross-section parallel to the flow direction 
simulated by COMSOL. Velocities and shear rates correspond to 2 L/min. Not far from 
the beads the flow profile nears Poiseuille conditions and is essentially undisturbed by the 
bead patterns. The shear rate along the z-direction above the bead center and above the 
two bead contact point at various height points were computed and shown in (B). Greater 
than two bead diameter from the glass surface, velocity differences between the two 
points are effectively zero and the flow is no longer disturbed by the imposed roughness. 
Reprinted with permission from Effect of Surface Nanotopography on Immunoaffinity 
Cell Capture in Microfluidic Devices. 55 Copyright (2011) American Chemical Society. 
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2.3.3 Capture of Glutaraldehyde Fixed Cells on Silica-Nanobead Substrates 
To evaluate the hypothesis that cell mechanical properties influence their capture, Jurkat 
cells were fixed with 1% glutaraldehyde and used in capture experiments under 5 l/min 
flow. Glutaraldehyde crosslinks amine groups and thus can increase the Young’s 
modulus of cells by greater than an order of magnitude. 78 Figure 2.6 shows the 
normalized capture efficiency of fixed cells: capture efficiency increases slightly for the 
smallest nanobead layers then gradually decreases. With fixed cells no dip in cell capture 
efficiency is seen and the surface topography effects are greatly dampened as no 
statically significant difference was found no matter when neighboring data points were 
compared or when the capture on nanobeads were compared to that on flat TEOS.  
 
Figure 2.6: Capture of glutaraldehyde-fixed Jurkat cells from culture media onto 
nanobead-patterned substrates at 5μl/min. Numbers of cells captured on nanobeads were 
normalized to those captured on flat TEOS-coated surfaces. The error bars represent one 
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standard deviation as calculated from greater than four repeats of each condition. p value 
was found to be greater than 0.126 for every data point, either comparing with capture 
efficiency on TEOS or its preceding neighbor, indicating that capture on the various 
surfaces was not significantly different. Reprinted with permission from Effect of Surface 
Nanotopography on Immunoaffinity Cell Capture in Microfluidic Devices. 55 Copyright 
(2011) American Chemical Society. 
To further verify the different capture between live and fixed cell, live (triangles in 
Figure 2.7) and fixed (dots) Jurkat cells were mixed at a 1:1 ratio for capture on 490nm 
beads under 5 l/min (empty symbols) and 8 l/min flow (solid symbols). As shown in 
Figure 2.7, the normalized capture efficient is consistent with the results in Figure 2.4 
and Figure 2.6 using live or fixed cells alone under the respective conditions. In addition, 
capture of glutaraldehyde-fixed cells is much less sensitive to change in surface 
roughness: under 5 l/min flow, the p-value is 0.7597 when comparing capture of fixed 
cells on 490 nm bead monolayers to that on smooth TEOS, while there is a significant 
difference for live cell capture on the two surfaces (p = 0.0002). Live cell capture is also 
highly sensitive to the flow rate, showing by the significant difference of capture 
efficiency at the two tested flow rates (p = 0.00518).   
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Figure 2.7: Capture of glutaraldehyde-fixed and live Jurkat cell mixture (1:1 ratio) from 
culture media onto 490 nm nanobead-patterned substrates at 5μl/min and 8μl/min. 
Numbers of cells captured on nanobeads were normalized to those captured on flat 
TEOS-coated surfaces. The error bars represent one standard deviation as calculated from 
greater than three repeats under each condition. Data point labeled with * have a 
statistically different cell capture compared with the capture on TEOS with p < 0.1. 
Reprinted with permission from Effect of Surface Nanotopography on Immunoaffinity 
Cell Capture in Microfluidic Devices. 55 Copyright (2011) American Chemical Society. 
To test if glutaraldehyde fixation interferes with antibody-antigen binding chemistry, we 
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fixed Jurkat cells with glutaraldehyde and then stained the nuclei with Hoechst 33258.  
Afterwards, fixed and stained Jurkat cells were mixed with live cells at a 1:1 ratio. The 
cell mixture was manually injected into a PDMS microchannel bonded to functionalized 
bare glass and incubated under static conditions for 15 minutes. The device was rinsed 
and captured cells were counted. Figure 2.8 shows a representative image. Average cell 
counts from multiple devices and imaging areas show that identical numbers of fixed and 
untreated cells were captured. This suggests that the different capture profiles of live and 
fixed cells are not due to altered antibody-antigen interactions.  
 
Figure 2.8: Representative bright field image showing the capture of glutaraldehyde-
fixed (blue) and live (grey) Jurkat cells mixed 1:1 in culture media on antibody-
functionalized bare glass substrates under static incubation. Average cell counts from 
multiple devices and imaging areas show that identical numbers of fixed and untreated 
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cells were captured. This indicates that the fixation procedure does not interfere with 
antibody-antigen recognition. Scale bar = 50μm. Reprinted with permission from Effect 
of Surface Nanotopography on Immunoaffinity Cell Capture in Microfluidic Devices. 55 
Copyright (2011) American Chemical Society. 
A direct outcome of glutaradehyde fixation is significant enhancement of cell moduli. 78 
Live CD4+ cells have a flexible membrane undulating even in static culture medium. The 
varying levels of shear deformation under different flow rates are expected to influence 
the interaction area between cells and antibody-coated substrates. Although shear 
deformation on the cellular level may contribute to the flow rate dependent capture, it 
does not fully explain cell interaction with nanotopography, which is an order of 
magnitude smaller than cell dimension in our study.  
 
 
Figure 2.9: A confocal Z-stack image showing tethers from a Rhodamine B stained 
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Jurkat cell to an antibody functionalized smooth glass substrate (scale bar = 2 µm). After 
cell capture from continuous flow on an antibody treated smooth glass slide, the flow was 
stopped and confocal images were acquired. The fluid flowed from the right to the left for 
cell capture and the substrate locates at the bottom of the image indicated by a dash line. 
The fuzziness of the membrane away from the substrate is a result of spontaneous 
membrane fluctuation. Reprinted with permission from Effect of Surface 
Nanotopography on Immunoaffinity Cell Capture in Microfluidic Devices. 55 Copyright 
(2011) American Chemical Society. 
Instead, a more plausible explanation of the capture dependence on surface nano-features 
and wall shear stress may arise from protruding nano-structures on the cell membrane.  
The predominant features on the surface of human lymphocytes are microvilli that consist 
of bundles of cross-linked actin filaments. 79 CD4 receptors, the target antigen in this 
study, are preferentially located on the microvilli ends. 80 Indeed, we observed cell 
extensions a few hundred nanometers in diameter tethered to antibody functionalized 
substrates (Figure 2.9), indicating interactions between membrane nanostructures and the 
capture bed. With a dimension of 300 to 400 nm in length, ~100 nm in width, and a 
spatial distribution of ~4/μm, 79 microvilli are comparable in size to the nanobeads used 
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in this study. This comparable dimension scale suggests a physical complementarity 
between certain substrate nanotopographies and the cell surface in addition to specific 
antibody-antigen interactions. Complementary interactions have been reported with 
nanopillars to enhance the capture yield of circulating tumor cells. 17 Optimal capture 
yield occurs with 6 µm or longer nanopillars which are on the same length scale as the 
protrusion lengths of tumor cells. 17 In our system, while the amount of immobilized 
antibody increases continuously with the nanobead diameter, 67 the physical 
complementarity has a non-monotonic dependence on the nanoparticle size. The interplay 
of the two factors may strongly contribute to the complex capture profiles on the 
nanostructured surfaces. Interestingly the tethers observed in Figure 2.9 are much longer 
than the length of microvilli measured on unattached lymphocytes. 79 These long 
extensions may be a result of microvilli being stretched after initial tethering. The 
diameter of these extensions is also slightly thicker than those measured by AFM or 
SEM, 79 likely due to optical diffraction. Since microvilli are susceptible to shear forces, 
highly dynamic and deformable to help cells contact and bind to patterned substrates, 81,82 
they can experience different shear deformation and contribute to the flow dependence of 
the cell capture. While fixed cells also present microvilli, 79 their lack of dynamics and 
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weak response to shear forces makes capture of fixed cells much less sensitive to the 
surface topography.  
2.4 Conclusions  
Close-packed silica bead layers provide a powerful tool to systematically control surface 
roughness and enhance immunoaffinity cell capture under continuous flow. Interestingly, 
complicated cell capture efficiency profiles were observed across several flow rates and 
surface nanotopographies. Hardening cells through glutaraldehyde fixation significantly 
dampened this dependence. The non-monotonic relationships between the capture 
efficiency and surface roughness under various flow rates are likely results of 
complementarity and shear deformation of nano-protrusions on the cell membrane. In 
future studies, we plan to extend the length scale and investigate the influence of 
substrate microstructures on cell capture. This relationship between surface topography 
and cell capture efficiency, once established, will enable more rational design of cell 
capture devices. 
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Chapter 3 
Short Term Culture, Long Term Culture and 
Neural Differentiation of Neural Stem Cell 
Line C17.2 in Microfluidics 39 
3.1 Motivation 
Neural stem cells (NSCs) have recently attracted significant interest for their promise in 
treating neurodegenerative disorders, such as Alzheimer’s disease, ischemia and 
Parkinson’s disease. 83–92 Despite progress in neuronal cell differentiation and 
transplantation of NSCs, future success will require further understanding of the neuronal 
cell differentiation mechanisms. 84,86,87,89,91,93–101 Microfluidics has recently been shown 
to be a powerful tool in stem cell research, due to the advantage of precise control of 
individual environmental cues, single cell analysis, real-time measurement and easy 
integration with electrical stimulation. 41,102–118 Concentration gradients of cytokine or 
growth hormone have been created in microfluidic devices to quantitatively study 
chemical and biological cues that initiate or facilitate neuronal cell differentiation. 
32,41,119–121 Microfluidics have also been used to introduce mechanical or topographical 
stimulation for the analysis of non-chemical cues on neuronal cell differentiation. 122,123 
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However, transferring NSC research from traditional petri dish to microfluidics requires 
careful optimization of the chemical and physical culture conditions in microfluidics. The 
use of microfluidics in NSC research also presents an issue with regard to dynamic 
nutrient concentration. As the culture volume is miniaturized, nutrient consumption from 
cell metabolism is much more pronounced than conventional bulk culture, while it is well 
established that NSCs are extremely sensitive to serum depletion. In vivo neuronal cell 
differentiation of NSCs occurs when there is a shortage of blood and oxygen supply, as 
studied in disease models like ischemia. 86,96,97,124–129 For in vitro cultures, serum 
withdrawal is often used to induce neuronal differentiation of NSC. 130–132 Based on the 
available knowledge up to date, we hypothesize that NSCs could undergo neuronal cell 
differentiation even in the regular NSC culture media if the volume of media available is 
limited, which after cell metabolism quickly becomes nutrient depleted. Shear stress also 
has a significant impact in stem cell differentiation. Many publications show that shear 
stress determines cell fate or helps to enhance differentiation in different types of stem 
cells, 133–137 including neural stem cells.138 While it is desirable to induce differentiation 
through controlled biological, chemical and physical cues, spontaneous differentiation 
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needs to be characterized to guide microfluidic design and avoid its interference with 
mechanistic studies.  
Here in this chapter, we optimized the chemical and physical conditions to culture C17.2 
NSCs in microfluidics through short term culture and then used microfluidic devices to 
control the amount of culture medium available and characterized the phenotype of C17.2 
NSCs over three weeks in standard culture medium to analyze its long term culture and 
differentiation. C17.2 is an immortalized mouse neural progenitor cell line established by 
retroviral-mediated transduction of the avian myc oncogene into mitotic progenitor cells 
of neonatal mouse cerebellum, and an important model system in studies of neural 
regeneration. 92–94,130–132,139–144 C17.2 NSCs have shown the ability to successfully 
integrate into the central nervous system of animals used as disease models for 
Parkinson’s, stroke and Alzheimer’s. 91–94 Both in vivo and in vitro studies also 
demonstrate that C17.2 NSCs undergo neuronal cell differentiation under nutrient 
depletion, 92,94,130–132,141 which makes them an appropriate cellular model for this work. A 
medium factor (MF) was used as a quantitative measure of available medium to each cell 
per unit time. The MF was defined as the volume of culture medium normalized to the 
total number of cells at seeding and the feeding period. It was controlled using 
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microchannels of various heights, since it is otherwise difficult to reduce the height of 
culture media to below one millimeter in conventional bulk culture, considering the 
meniscus. Another strategy to control MF was to vary the feeding frequency, with higher 
frequency making more fresh medium available to each cell over time. Cell morphology 
and quantified immunocytochemistry results were examined to verify the correlation 
between the resulting differentiated cell population and the MF. Critical thresholds of MF 
to maintain the stem cell characteristics were identified. The range of consumption rate of 
serum molecules involved in the process is also discussed here.   
3.2 Materials and Methods  
3.2.1 Cell Culture  
Immortalized murine neural progenitor cells C17.2 (established cell line 92–94,130–132,139–144 
as a generous gift to the Jedlicka Lab from Dr. Evan Snyder, of the Sanford-Burnham 
Medical Research Institute) were grown on 100 mm polystyrene tissue culture dishes 
(BioLite, Fisher Scientific) at 37 °C in 5% CO2 in air. The culture medium consisted of 
high glucose Dulbecco’s modified Eagle medium (DMEM) (HyClone, Fisher Scientific) 
supplemented with 10% fetal bovine serum (HyClone, Fisher Scientific), 5% horse serum 
(TCS Biosciences) and 2 mM L-glutamine (MP Biomedicals).  
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3.2.2 Microfluidic Device Fabrication  
Polydimethylsiloxane (PDMS) microchannels were prepared following the standard soft 
lithography protocol. Two types of molds were used in this study: SU8 was patterned on 
silicon wafers for devices with 50 µm and 250 µm heights; micromachined steel molds 
were used for devices with 500 µm, 1 mm and 2 mm heights. All devices had the same 
footprint of 1 cm  4 mm (L  W). A 10:1 mixture of silicone elastomer base and silicone 
elastomer curing agent (Sylgard 184 silicone elastomer kit, Dow Corning Corporation) 
was poured onto the molds, degassed, cured at 65-75 °C and the microdevices were cut 
out. Fluid inlets and outlets were drilled using a syringe needle. Microchannels were then 
autoclaved at 121 oC for 1 hour. Afterwards, glass bottomed petri dishes (FluoroDish, 
World Precision Instruments) and the PDMS microchannels were activated by oxygen 
plasma, carefully aligned and heated for 5-10 minutes at 65-75 °C to produce permanent 
bonding. The control (a standard microwell culture) and one packaged microfluidic 
device are shown in Figure 3.1.  
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Figure 3.1: A control and PDMS bonded FluoroDish for cell culture. (A) A standard bulk 
culture on FluoroDish was used as the control. (B-C) PDMS microchannels with a 
footprint of 1 cm  4 mm (L  W) and various heights (50 µm, 250 µm, 500 µm, 1 mm 
and 2 mm) were permanently bonded to FluoroDish to control the amount of medium 
available to cells. The microchannels were autoclaved prior to bonding and cell culture. 
Reprinted with permission from Maintenance and neuronal cell differentiation of neural 
stem cells C17.2 correlated to medium availability sets design criteria in microfluidic 
systems. 39 Copyright: © 2014 Wang et al. 
3.2.3 Short Term C17.2 NSC Culture with Different Substrate Chemistry  
A number of substrate materials commonly used in microfluidic systems and two 
standard coating methods were tested to identify the substrate for the optimum adhesion 
of C17.2. Glass bottomed petri dish (35mm cell culture fluorodish, World Precision 
Instruments) was used as purchased. Cover glass slides (Fisherbrand microscope cover 
glass, Fisher Scienctific) were autoclaved at 134oC for 1 hr before coating and usage. 
PDMS substrates were made by pouring 1.1g of 10:1 mixture of silicone elastomer base 
and silicone elastomer curing agent into each well of a 6-well plate. After PDMS 
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substrates were cured at 65 oC -75 oC, they were cut out and treated by either UV light 
overnight or autoclaving at 134oC for 1 hr before coating.  
Autoclaved cover glass, UV-treated PDMS and autoclaved PDMS were coated with 
either collagen or poly-L-lysine to enhance cell adhesion. Collagen (rat tail type I 
collagen, BD Biosciences) was diluted to 0.1mg/ml by 30% ethanol in deionized water, 
added to the substrates, treated by UV light overnight and washed 3 times with PBS 
before use. Poly-L-lysine (MP Biomedicals) was diluted to 0.1mg/ml by PBS, left on 
substrates for 1 hr, washed with PBS 3 times, let dry for 2 hrs and washed with PBS 3 
times again before use.  
To test cell adhesion on different substrates, C17.2 cells were treated by trypsin (Hyclone 
trypsin 0.25%, Fisher Scientific) and seeded onto substrates at 25,000 cells/cm2 surface 
density. After 1 day, 3 images were taken from each sample to examine cell adhesion.  
Image Processing and Analysis in Jave (ImageJ, National Institutes of Health) was used 
to count the number of pixels covered by cells and the total pixels in an image. The 
percentage of area covered by cells (the number of pixels covered by cells divided by the 
total pixels in an image) after 1 day of culture was used to quantify cell adhesion on 
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different substrates. The substrate with best cell adhesion results was used in further 
experiments.  
3.2.4 Short Term C17.2 NSC Culture in Microchannels with Different Physical 
Environment  
To test cell adhesion and proliferation under different flow patterns, C17.2 cells were 
treated by trypsin and injected into microchannel at 25,000 cells/cm2 surface density. 
After 3 hrs, 3 images were taken for each sample to examine cell adhesion.  Then a 
syringe (1ml plastic syringe, BD Biosciences) loaded with regular cell medium was 
connected to the microchannel through tubing (Tygon AAQ04091, Saint-Gobain). The 
flow rates of both continuous and periodic flows were controlled by a syringe pump 
(Fusion Touch400, Chemyx Inc.). Cells in the continuous flow group were subjected to a 
continuous flow of 1, 2, 3 and 4 µL/hr. Cells in the periodic flow group were subjected to 
a pulse flow of 50, 150, 250, 350, 450 and 550 µL/hr for a total volume of 5 µL every 12 
hrs. Under all flow conditions, the cell medium in a microchannel was refreshed more 
than 2 times in 12 hrs. After 1 day, 3 images were taken for each sample to compare with 
images taken after 3 hrs. ImageJ was used to count the number of pixels covered by cells 
and the total pixels in an image. The percentage of area covered by cells in an image after 
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1 day of culture divided by the percentage of area covered by cells in an image after 3 hrs 
(normalized area cover by cells per image) was used to quantify cell adhesion and 
proliferation under different flow patterns.  
3.2.5 Long Term C17.2 NSC Culture and Neural Differentiation in Microchannels  
Trypsinized and suspended C17.2 NSCs were injected into microchannels of different 
heights: 50 µm, 250 µm, 500 µm, 1 mm and 2 mm. The suspension concentration was 
adjusted so the surface density was comparable in all devices and was ~25,000 cells/cm2 
after initial cell adhesion. After allowing the cells to adhere for 3 hours, the cells were fed 
periodically every 12, 24, 48 or 96 hours using a syringe pump. Flow rates were used to 
generate a comparable wall shear stress of 0.004 Pa in all devices. A total of 2.5 times the 
device volume was injected at every time interval to ensure complete medium 
replacement. Table 3.1 summarizes the conditions used. The flow pattern and feeding 
interval combination was determined by preliminary experiments. As a control, C17.2 
cells were seeded at the same surface density into a FluoroDish without any 
microchannel. The medium in the control was withdrawn completely and replaced every 
48 hours (standard subculture feeding frequency). All devices were kept under 
humidified environment at 37 °C in 5% CO2 in air. Three samples in each condition were 
58 
 
immunostained after 1 week, 2 weeks and 3 weeks of culture to monitor the cell 
phenotype over time. At least five images were captured at random locations from each 
sample, thus a total of 15 images or more were analyzed under each condition. 
Table 3.1: The microchannel geometries and feeding conditions used in this study.  
Reprinted with permission from Maintenance and neuronal cell differentiation of neural 
stem cells C17.2 correlated to medium availability sets design criteria in microfluidic 
systems. 39 Copyright: © 2014 Wang et al. 
Microchannel 
height (µm) 
Flow rate for cell 
feeding (µL/hr)  
Vol. of 
medium (µL)  
Feeding interval 
(hour) 
50 250 5 12 24 48 - 
250 6,250 25 12 24 48 - 
500 25,000 50 12 24 48 - 
1000 100,000 100 12 24 48 - 
2000 400,000 200 - 24 48 96 
 
3.2.6 Immunostaining  
Cells were fixed in 3.7% paraformaldehyde (Sigma-Aldrich) for 15 min, permeabilized 
with 0.1% Triton X-100 (Fisher Scientific) in phosphate buffered saline (PBS, Fisher) for 
15 min, and blocked by 1% bovine serum albumin (BSA, Sigma-Aldrich) in 0.01% 
Triton X-100 for 15 min at room temperature. Both primary and secondary antibodies 
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were diluted in 0.1% BSA and 0.001% Triton X-100 solution and then incubated with 
cells overnight for 8-10 hrs at 4 °C. Primary antibodies used were Nestin (clone Rat-401, 
Fisher Scientific), anti-β-tubulin-III (AlexaFluor488, clone TUJ1, BD Biosciences) and 
anti-MAP2 antibody (AlexaFluor488, clone AP20, Chemicon). The secondary antibody 
for Nestin was AlexaFluor546 anti-mouse IgG1 (Invitrogen). Finally cell nuclei were 
stained with 0.002 mg/ml Hoechst No. 33258 (Invitrogen) for 5 min. After rinse, 5 
images were captured from each sample using phase-contrast and fluorescence 
microscopy (Eclipse TE2000U, Nikon). The surface area in each image was 0.15 mm2. 
The average number of β-tubulin-III positive cells per mm2 was calculated to characterize 
the onset of neuronal cell differentiation. MAP2 staining was carried out in selected sets 
of samples: 50 µm tall microchannel samples under a 48 hr feeding interval, 2 mm tall 
microchannel samples under a 48 hr feeding interval and fluorodish samples under a 48 
hr feeding interval, to confirm the results from β-tubulin-III staining.  
3.2.7 Neurite Measurement  
The lengths of neurites were measured using immunostained images. Cells with positive 
staining by β-tubulin-III and neurite outgrowth greater than two times the size of soma 
were considered as neuronal cells. Neurite outgrowth from each neuronal cell was 
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measured by the NeuronJ plugin in ImageJ (National Institutes of Health). The average 
number of neuronal cells per mm2 was used to characterize neuronal cell differentiation. 
The average neurite length (total neurite length divided by the number of neurites in an 
image) was also calculated. 
3.2.8 Medium Factor (MF) 
The MF was introduced to quantify the amount of medium available to cells over the 
feeding period. It was calculated by the following equation:  
MF =
tP
V

 
Where V is the volume of culture medium, P is the total number of cells at seeding, t is 
the time interval between two feeding events. 
3.2.9 Data Analysis  
All data sets in graphs are presented as average ± standard deviation from repeats in at 
least three independent devices. When comparing multiple samples in a group, one-way 
ANOVA test was used with a p-value of 0.05. When comparing test samples to the 
control, two-tailed Student’s t test was used with a p-value of 0.05.  
3.3 Results and Discussions  
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3.3.1 Short Term C17.2 NSC Culture with Different Substrate Chemistry 
In traditional cell culture, poly-styrene is often used as the substrate because it can be 
readily oxidized, leaving the surface suitable for cell adhesion. 145 In microfluidics 
systems, PDMS and glass are often used because they can be easily packaged using 
oxygen plasma. When moving cells from traditional substrate to new ones, the first step 
is inevitably to make sure the surface is suitable for cell spreading and adhesion. While 
the materials themselves are important, the way they are processed and whether they are 
coated with cell adhesion molecules are also crucial to optimize cell adhesion. In this 
experiment, glass cover slides, glass bottomed petri dish and PDMS were used as 
substrate materials. When sterilizing glass, autoclaving was used as sterilization method 
(A-Glass). Both UV light (UV-PDMS) and autoclaving methods (A-PDMS) were tested 
on PDMS because UV light merely sterilizes PDMS while autoclaving is believed to 
further crosslink PDMS and evaporate solvent residues. 146,147 Two cell adhesion 
molecules, collagen (abbreviated as C) and poly-L-lysine (abbreviated as PLL) were also 
used to enhance the results.  
C17.2 cells were given 1 day to adhere to substrates after seeding. The percentage of area 
covered by cells in an image was used to quantify cell adhesion on different substrates. 
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PDMS itself, whether sterilized by UV or autoclaving, showed very little promise for cell 
adhesion, probably due to its high hydrophobicity. Autoclaved glass showed slightly 
better results (p=0.00023 compared with UV-PDMS, p=0.00032 compared with 
autoclaved-PDMS, p<0.1. Comparison group is labeled with **). Both collagen and PLL 
coating improved cell adhesion on PDMS and glass as expected (p range from 0.000008 
to 0.047, p<0.1). Interestingly collagen improved cell adhesion to different degrees on 
different materials and even on the same material with different sterilization treatment 
(UV-PDMS with collagen coating in Figure. 3.1B and autoclaved-PDMS with collagen 
coating in Figure. 3.1E, p=0.00031, p<0.1. Comparison group is labeled with ***). This 
is the result of complex driving forces behind the assembly of the coating molecules itself 
and the interaction between coating molecules and the substrate.61, 62 Glass-bottomed 
petri dish had the best cell adhesion and was chosen as the substrate material to conduct 
further experiments (p range from 0.0001 to 0.048, p<0.1. Labeled with *.).  
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Figure 3.1. Cell morphology after adhesion on different substrates. The morphology 
of C17.2 cells after 3 hours of adhesion on (A) UV sterilized PDMS (UV-PDMS), (B) 
UV-PDMS coated with collagen (UV-PDMS/C), (C) UV-PDMS coated with poly-L-
lysine (UV-PDMS/PLL), (D) autoclaved PDMS (A-PDMS), (E) autoclaved PDMS 
coated with collagen (A-PDMS/C), (F) autoclaved PDMS coated with poly-L-lysine (A-
PDMS/PLL), (G) autoclaved glass (A-Glass), (H) autoclaved glass coated with collagen 
(A-Glass/C), (I) autoclaved glass coated with poly-L-lysine(A-Glass/PLL) and (J) glass 
bottomed petri dish (Glass petri dish). Glass bottomed petri dish had the best cell 
adhesion and was chosen as the substrate material for further experiments. Scale bar=100 
µm. 
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Figure 3.2: Cell adhesion on different substrates. C17.2 cell adhesion was tested on UV 
sterilized PDMS (UV-PDMS), UV-PDMS coated with collagen (UV-PDMS/C), UV-
PDMS coated with poly-L-lysine (UV-PDMS/PLL), autoclaved PDMS (A-PDMS), 
autoclaved PDMS coated with collagen (A-PDMS/C), autoclaved PDMS coated with 
poly-L-lysine (A-PDMS/PLL), autoclaved glass (A-Glass), autoclaved glass coated with 
collagen (A-Glass/C), autoclaved glass coated with poly-L-lysine(A-Glass/PLL) and 
glass bottomed petri dish (Glass petri dish). Glass bottomed petri dish (with *) had 
statistically higher cell adhesion comparing to the rest (p<0.1) and was chosen as the 
substrate material for further experiments. N=4. 
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3.3.2 Short Term C17.2 NSC Culture in Microchannels with Continuous and 
Periodic Flow 
Two approaches can be employed to culture cells in microfluidics: continuous flow 
generating low shear stress over the whole course of culture or periodic flow generating 
larger shear stress over a short time. Given that little has been done to culture C17.2 in 
microchannels, we examined both approaches. C17.2 cells were seeded into 
microchannel and fed with continuous flow of 1, 2, 3 and 4 µL/hr or periodic flow of 50, 
150, 250, 350, 450 and 550 µL/hr for a total volume of 5 µL every 12 hrs. The percentage 
of area covered by cells in an image after 1 day of culture divided by the percentage of 
area covered by cells in an image after 3 hrs (normalized area cover by cells per image) 
was used to quantify cell adhesion and proliferation under different flow patterns. As 
shown in Figure. 3.3 and Figure. 3.4, a continuous flow of 2 µL/hr and 3 µL/hr resulted 
in the highest cell adhesion and proliferation over a range of flow rates, while a periodic 
flow of 250 µL/hr was optimal for cell adhesion and proliferation. In both cases, 
diversion from the optimal flow rate resulted in a progressive decrease in cell adhesion 
and proliferation. As we compare the results from both continuous and periodic flow 
groups, significantly increased cell proliferation was observed in periodic flow group 
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under flow rates of 150, 250, 350 and 450 µL/hr compared to the best result from the 
continuous flow group. The flow pattern yielding the best adhesion and proliferation 
result, a periodic flow of 250 µL/hr, was used for later experiments. 
 
Figure 3.3: Cell adhesion and proliferation in 50 µm microchannel with continuous flow 
of regular stem cell culture medium. C17.2 cell adhesion and proliferation was tested in 
50 µm tall microchannel with continuous flow of 1, 2, 3 and 4 µL/hour.  (A-D) Cell 
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morphologies after 1 day of continuous flow of medium at different flow rates. (S1.E) 
The surface area covered by cells after 1 day of culture was normalized to that after 3 
hour of static adhesion (E) to estimate the number of cells in the microchannels. 
Continuous medium feeding at 3 µL/hour yielded the highest number of adherent cells 
after 1 day of continuous flow, but little cell proliferation was observed. Scale bar=100 
µm. N15. Reprinted with permission from Maintenance and neuronal cell differentiation of 
neural stem cells C17.2 correlated to medium availability sets design criteria in microfluidic 
systems. 39 Copyright: © 2014 Wang et al. 
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Figure 3.4: Cell adhesion and proliferation in 50 µm microchannel with periodic flow of 
regular stem cell culture medium. C17.2 cell adhesion and proliferation was tested in 50 
µm tall microchannel with periodic flow of 50, 150, 250, 350, 450 and 550 µL/hour 
administered every 12 hours. (A- D) Cell morphologies after 1 day of continuous flow of 
medium at different flow rates. (E) The surface area covered by cells after 1 day of 
culture is normalized to that after 3 hour of static adhesion (E) to estimate the number of 
cells in the microchannels. Periodic medium feeding at 250 µL/hour every 12 hours 
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yielded the highest number of adherent cells and significant cell proliferation after 1 day 
of continuous flow. Scale bar=100 µm. N15. Reprinted with permission from 
Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated to 
medium availability sets design criteria in microfluidic systems. 39 Copyright: © 2014 
Wang et al. 
3.3.3 Short Term C17.2 NSC Culture in Microchannels under Different Frequencies 
Different frequencies to feed C17.2 cells in 50 µm tall microchannel with a periodic flow 
of 250 µL/hour were examined. The percentage of area covered by cells in an image after 
1 day of culture divided by the percentage of area covered by cells in an image after 3 hrs 
(normalized area cover by cells per image) was used to quantify cell adhesion and 
proliferation under different flow patterns. Cell morphologies after 1 day of continuous 
flow of regular stem cell culture medium at different flow rates is shown in Figure 3.5A-
D. In Figure 3.5E, the surface area covered by cells after 1 day of culture was 
normalized to that after 3 hour of static adhesion to estimate the number of cells in the 
microchannels. Periodic medium feeding at 250 µL/hour administered every 12 hours 
yielded the highest number of adherent cells after 1 day of continuous flow. Feeding 
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periods less than 12 hours led to significant less adherent cells in the device. Thus, only 
feeding periods of 12 hours or higher were used in the work. 
 
Figure 3.5: Cell adhesion and proliferation under different frequencies. C17.2 cell 
adhesion and proliferation was tested under different feeding frequencies in 50 µm tall 
microchannel with a periodic flow of 250 µL/hour. (A- D) Cell morphologies after 1 day 
of continuous flow of regular stem cell culture medium at different flow rates. (E) The 
surface area covered by cells after 1 day of culture was normalized to that after 3 hour of 
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static adhesion to estimate the number of cells in the microchannels. Periodic medium 
feeding at 250 µL/hour administered every 12 hours yielded the highest number of 
adherent cells after 1 day of continuous flow. Feeding periods less than 12 hours led to 
significant less adherent cells in the device. Thus, only feeding periods of 12 hours or 
higher were used in the work. Scale bar=100 µm. N15. Reprinted with permission from 
Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated to 
medium availability sets design criteria in microfluidic systems. 39 Copyright: © 2014 
Wang et al. 
3.3.4 Long Term C17.2 NSC Culture in Microchannels  
To test if the neuronal cell differentiation can be induced by shear stress, cell population 
in 2000 μm microchannels was compared to that in bulk culture (Figure 3.6), as the MF 
factors were similar in these cases. Little morphological and biomarker change was 
observed over time in all samples (images not shown), demonstrating minimal neuronal 
cell differentiation. When the results were quantitatively analyzed, the cell population 
with the 24 hr feeding intervals showed lower number of β-tubulin-III positive cells 
compared to the control (Figure 3.6A) at 1 week (with * above, p=0.00004). This is 
possibly due to more thorough medium replacement in microfluidics as compared to 
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traditional pipetting in petri dishes: the channel is flushed with fresh medium 2.5 times 
the channel volume at every cell feeding, while in traditional petri dish culture, the old 
medium is suctioned up and replaced with equal volume of fresh medium once. The rest 
of the microfluidic samples shared comparable number of β-tubulin-III positive cells to 
the control (p values range from 0.08 to 0.9). As shown in Figure 3.6B, all samples had 
lower number of neuronal cells compared to the control in the first week (p values range 
from 0.02 to 0.04), but the difference diminished later. From Figure 3.6C, it was 
observed that the average neurite length of most samples were similar to the control 
except for those without noticeable neurite outgrowth (with “O” in Figure 3.6B and 
Figure 3.6C). The ANOVA tests for samples from the same time points demonstrated 
comparable density of -tubulin-III cells and neurite length in the 2000 μm channels. The 
density of neuronal cells were significantly different under the various feeding intervals 
(brackets and * underneath the groups, p<0.05), but the difference was due to a reduced 
neuronal density than the control. The neurite length was comparable. The ** under the 
groups in Figure 3.6C and 3.6D indicate difference due exclusively to the samples with 
zero positive cells. These results show that the neuronal cell differentiation cannot be 
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initiated by introducing shear stress generated by feeding in microfluidics over long term 
culture.  
 
Figure 3.6: Behavior of C17.2 cells cultured in microchannels under shear stress. (A) 
The β-tubulin-III positive cell counts per mm2 over time. (B) The neuronal cell counts per 
mm2 over time. (C) The average neurite length per mm2 over time. Groups lacking 
neuronal cells were labeled with “O”. The control (with “c”) was C17.2 NSCs seeded at 
the same surface density in FluoroDishes but without microchannels and fed every 48 
hours as in standard subculture protocols. The * above the bars indicated a statistical 
difference between the sample and the control by two-tailed Student’s t test (p <0.05). 
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The * below the bars indicated a statistical difference in the group by one way ANOVA 
(p <0.05). The ** in Figure C indicates a significant difference due exclusively to the 
samples with no neurite outgrowth. N15. Reprinted with permission from Maintenance 
and neuronal cell differentiation of neural stem cells C17.2 correlated to medium 
availability sets design criteria in microfluidic systems. 39 Copyright: © 2014 Wang et al. 
3.3.5 C17.2 Differentiation in Microchannels with Different Heights but Fixed 
Feeding Frequency  
First, we examined C17.2 NSCs cultured in microchannels with different heights under 
fixed feeding frequency. In this case, the MF scales linearly with the microchannel 
height. As a control, cells were seeded at the same surface density in FluoroDish without 
microchannels (with “c” in all graphs). The average medium height in the open culture is 
~2 mm, calculated by the volume of medium divided by the surface area of the dish 
bottom, and the cells were fed every 48 hours as in standard subculture protocols.   
The progression of cell morphology over time is shown in Figure 3.7A and the 
quantified immunocytochemistry results are shown in Figure 3.7B-D. As shown in 
Figure 3.7A, groups with lower MF values (50 μm, 250 μm and 500 μm microchannels) 
began to have morphological change consistent with neuronal cell differentiation after 1 
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week. This trend became dominant after 2 weeks with the 50 μm microchannel yielding 
almost a pure population of cells with neurite outgrowth and positive β-tubulin-III 
staining. On the other hand, Nestin staining (red) weakened on the elongated cells, and 
became nearly undetectable in the 50um group in week 2, also suggesting neuronal cell 
differentiation. When the images were analyzed quantitatively, the cell populations in 50 
μm, 250 μm and 500 μm microchannels were found to show significantly higher number 
of β-tubulin-III positive cells compared to the control (with * above the bars, p values 
range from  0.00001 to 0.04) over the entire experimental course of 3 weeks (Figure 
3.7B). The β-tubulin-III positive cell number continued to grow over time, demonstrating 
an overall tendency towards the neuronal cell differentiation fate. However, neuronal 
cells (defined here as β-tubulin-III positive cells with neurite length longer than two times 
that of soma) peaked around 2 weeks and degenerated afterwards (Figure 3.7A and 
Figure 3.7C), as seen by reduction of the neuronal density and weaker β-tubulin-III 
staining at week 3. The 50 μm microchannel showed significantly higher number of 
neuronal cells compared to the controls (with * above, p values range from 0.0003 to 
0.0015) at all time points. The 250 μm microchannel showed significantly higher number 
of neuronal cells compared to the controls (with * above, p values are 0.013 and 0.028 
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respectively) in the first 2 weeks. The 500 μm microchannel showed significantly more 
neuronal cells than the control only in week 2 (with * above, p=0.001), but not in week 1 
or 3. The 1000 μm and 2000 μm samples, on the other hand, showed comparable or lower 
level of neuronal cell differentiation compared to the control, as demonstrated by lack of 
morphological change (images similar to those of the control, not shown) as well as the 
low number of β-tubulin-III positive cells (Figure 3.7B) and a baseline presence of 
neuronal cells (Figure 3.7C). For the 500 μm microchannel, the average neurite length 
was slightly higher than the control after 1 week of culture (with * above, p= 0.04). The 
average neurite length (Figure 3.7D) was the same for the rest of the test conditions and 
time points (p values range from 0.09 to 1), except for those lacking observable neurites 
(with “O” in Figure 3.7C and Figure 3.7D). The low level of neuronal differentiation 
limits the data points collected from the tall channels (1000 and 2000 μm), resulting in 
large standard deviation in Figure 3.7D. Samples from different channel heights but the 
same weeks were further analyzed using ANOVA. Groups with statistical difference 
among the samples (p<0.05) were marked by brackets and * underneath. For the density 
of -tubulin-III positive cells and neurons, the various device heights led to statistically 
different results at the same time point. For the neurite length comparison, the device 
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height did not create significant difference at week 1. The significant difference of neurite 
length observed at week 2 and week 3 (with ** underneath, p<0.05) was due exclusively 
to samples with zero neurite outgrowth in the groups. Thus, the neurite length was 
comparable among all samples with detectable neurite outgrowth at the same week.  
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Figure 3.7: Neuronal cell differentiation of C17.2 cells cultured in microchannels with 
different heights of 50-2000 µm under a 48 hr feeding interval. (A)The cell 
morphological change over 3 weeks. Images from the 1000 and 2000 micron samples 
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were not shown since they had similar morphology and staining results as the control for 
all three weeks. Red: Nestin. Green: β-tubulin-III. Blue: cell nuclei. In some samples, the 
β-tubulin-III staining was shadowed by the Nestin staining after triple overlay, due to the 
small number of spontaneously differentiated cells in these samples. In these samples, 
overlays of the β-tubulin-III and nuclei staining were shown in the inset from the boxed 
areas. Scale bar=50 µm. The insets were at the same scale as the main images. (B) The β-
tubulin-III positive cell counts per mm2 over time. (C) The neuronal cell counts per mm2 
over time. (D) The average neurite length measurement over time. Bars with “O” in 
Figure C and Figure D indicated that no cell was identified as a neuronal cell. In Figures 
B-D, the control (with “c”) was C17.2 NSCs seeded at the same surface density in 
FluoroDishes but without microchannels and fed every 48 hours as in standard subculture 
protocols. Data were shown as mean ± standard deviation. The * above the bars indicated 
a statistical difference between the sample and the control by two-tailed Student’s t test (p 
<0.05). The */** below the bars indicated a statistical difference in the group by the one-
way ANOVA test (p <0.05). The ** in Figure D indicated a significant difference due 
exclusively to the samples with no neurite outgrowth. N15. Reprinted with permission 
from Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated 
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to medium availability sets design criteria in microfluidic systems. 39 Copyright: © 2014 
Wang et al. 
3.3.6 C17.2 Differentiation in Microchannels with Fixed Geometry but Different 
Feeding Frequencies  
Next, cell behavior was compared for cultures fed under different frequencies but in 
microchannels with fixed heights. In this case, the MF scales linearly with the reverse of 
the time interval.   
The morphological change of cells in 50 μm microchannel over time is shown in Figure 
3.8A and the quantified immunocytochemistry results are shown in Figure 3.8B-D. In all 
the groups, cells began to develop smaller cell bodies and neurite outgrowth after 1 week 
(Figure 3.8A). After 2 weeks more cells showed neural morphology and positive β-
tubulin-III staining. At the same time, the β-tubulin-III staining became stronger as 
Nestin staining weakened. After 3 weeks of culture, the cells with long neurites started to 
deteriorate. Instead, another population with flattened cell body and relatively short and 
unbranched processes began to dominate, which co-expressed both Nestin and β-tubulin-
III. As shown in Figure 3.8B, the cell populations in 12 hr, 24 hr and 48 hr groups all 
showed significantly higher number of β-tubulin-III positive cells than the control in all 3 
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weeks (with * above, p values range from 0.00006 to 0.009). The β-tubulin-III positive 
cell number increased constantly over time, indicating a steady population growth in the 
overall neuronal cell differentiation path. The large error bars for samples in week 3 are 
caused by non-uniformly distributed cell population mixture associated with neuronal 
degeneration. The numbers of neuronal cells are shown in Figure 3.8C. The initial 
growth, peak growth and deterioration of neuronal cells were observed in all groups. At 
initiation and peak stages, all groups showed significantly higher number of neuronal 
cells compared to the control (with * above, p values range from 0.002 to 0.04). At week 
3, the difference in neuronal cell number between the microfluidic groups and the control 
diminished, except for the group with lowest MF (with * above, 48 hours, p =0.0003). 
The average neurite length was comparable for all groups (p values range from 0.15 to 1) 
as shown in Figure 3.8D. The large standard deviation of neurite length at week 3 is a 
result of neuronal degeneration, leaving behind a mixed population of cells with broad 
distribution of neurite length. The ANOVA test of different feeding conditions at each 
time point indicated that the feeding intervals significantly impacted the density of -
tubulin-III positive cells and neurons in the 50 m channels  (brackets and * underneath 
the groups, p<0.05), but not the neurite length (p>0.05).  
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The morphology change of cells over time in 250 μm microchannel is shown in Figure 
3.9A and the quantified immunocytochemistry results are shown in Figure 3.9B-D. The 
cell populations in 24 hr and 48 hr groups showed neurite outgrowth (Figure 3.9A) and 
significantly higher number (Figure 3.9B) of β-tubulin-III positive cells than the control 
at all time points (with * above the bars, p values range from 0.0003 to 0.03). However, 
the 12 hr group had minimal morphological change (Figure 3.9A) over 3 weeks. The 
numbers of β-tubulin-III positive cells in the 12 hr group were comparable to the control 
at all stages (p values range from 0.07 to 1). The numbers of neuronal cells are shown in 
Figure 3.9C. The initial growth, peak growth and deterioration of neuronal cells were 
observed in 24 hr and 48 hr groups. At the peak stage, groups with lower MF values, i.e. 
with 24 hr and 48 hr feeding intervals, showed significantly higher number of neuronal 
cells than the control (p=0.00004 and 0.028 respectively). The 12 hr group with higher 
MF started with significantly lower number of neuronal cells comparing to the control 
(with * above, p=0.03), but the difference became insignificant later (p=0.4 at 2 weeks 
and p=0.3 at 3 weeks). The average neurite length was comparable to the control for all 
the samples (p values range from 0.09 to 0.9) as shown in Figure 3.9D. The ANOVA test  
for the 250 m samples at each week also indicated that the density of -tubulin-III 
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positive cells and neurons changed significantly with the feeding intervals (brackets and * 
underneath the groups, p<0.05), but not the neurite length.  
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Figure 3.8: Neuronal cell differentiation of C17.2 cells cultured in 50 μm microchannels 
with 12, 24 and 48 hour feeding intervals. (A) The cell morphological change over 3 
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weeks. All groups showed biomarker staining and morphological change consistent with 
neuronal cell differentiation. Red: Nestin. Green: β-tubulin-III. Blue: cell nuclei. Scale 
bar=100 µm. (B) The β-tubulin-III positive cell counts per mm2 over time. (C) The 
neuronal cell counts per mm2 over time. (D) The average neurite length measurement 
over time. In Figures B-D, the control (with “c”) was C17.2 NSCs seeded at the same 
surface density in FluoroDishes but without microchannels and fed every 48 hours as in 
standard subculture protocols. Data were shown as mean ± standard deviation. The * 
above the bars indicated a statistical difference between the sample and the control by 
two-tailed Student’s t test (p <0.05). The * below the bars indicated a statistical 
difference in the group by one way ANOVA (p <0.05). N15. Reprinted with permission 
from Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated 
to medium availability sets design criteria in microfluidic systems. 39 Copyright: © 2014 
Wang et al. 
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Figure 3.9: Neuronal cell differentiation of C17.2 cells cultured in 250 μm 
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microchannels with 12, 24 and 48 hour feeding intervals. (A) The cell morphological 
change over 3 weeks. To better demonstrate the positive β-tubulin-III staining in the 24 
hour and 48 hour samples, overlays of the β-tubulin-III and nuclei staining were shown in 
the inset from the boxed areas. In comparison, insets of β-tubulin-III and nuclei staining 
were also shown for the 12 hour samples, but β-tubulin-III staining was not visible. Red: 
Nestin. Green: β-tubulin-III. Blue: cell nuclei. Scale bar=50 µm. The insets were from the 
boxed region and were at the same scale as the main images. (B) The β-tubulin-III 
positive cell counts per mm2 over time. (C) The neuronal cell counts per mm2 over time. 
(D) The average neurite length per mm2 over time. In Figures B-D, the control (with “c”) 
was C17.2 NSCs seeded at the same surface density in FluoroDishes but without 
microchannels and fed every 48 hours as in standard subculture protocols. Data were 
shown as mean ± standard deviation. The * above the bars indicated a statistical 
difference between the sample and the control by two-tailed Student’s t test (p <0.05). 
The * below the bars indicated a statistical difference in the group by one way ANOVA 
(p <0.05). N15. Reprinted with permission from Maintenance and neuronal cell 
differentiation of neural stem cells C17.2 correlated to medium availability sets design 
criteria in microfluidic systems. 39 Copyright: © 2014 Wang et al. 
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3.3.7 Confirmation of Differentiation by MAP2 Staining  
MAP2 staining was carried out in selected samples to confirm the differentiation 
characterization by β-tubulin-III staining. Here a MAP2 antibody targeting both MAP2a 
(expressed constitutively in neuronal cells) and MAP2b (expressed postnatal) isoforms 
was selected, so it stained differentiated neuronal cells at similar stages as the β-tubulin-
III antibody. The selected culture conditions are: 1) a condition in microchannels with the 
highest level of differentiation, i.e. 50 µm tall microchannel samples under a 48 hr 
feeding interval, 2) a condition in microchannels with MF equivalent to that of the 
control, i.e. 2 mm tall microchannel samples under a 48 hr feeding interval and 3) the 
open culture control, i.e. fluorodish samples under a 48 hr feeding interval. The 
morphology of the cells is shown in Figure 3.10A with MAP2 staining (green) overlaid 
with the phase contrast images. The insets show the overlaid MAP2 and nuclei staining. 
MAP2 staining was obvious only in the 50 m samples, but not the other two. The 
expression of MAP2 peaked at week 2 and decreased at week 3.  
The quantitative analysis of MAP2 staining is shown in Figure 3.10B-3.10D together 
with that of the -tubulin-III staining. The 50 µm microchannel samples demonstrated 
higher level of differentiation than the control (Figure 3.10B) marked by MAP2 and β-
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tubulin-III expression (with * above, p range from 0.0001 to 0.007) while both 
biomarkers demonstrated cells in the 2000 µm microchannels to be comparable to the 
control (p range from 0.66 to 0.96). When neuronal cells were counted by positive 
MAP2staining and neurite outgrowth greater than twice of the cell body, the dependence 
of neuronal cell density on the culture condition were comparable to the findings from -
tubulin-III staining (Figure 3.10C). MAP2 staining showed initiation, peak and 
degeneration of neuronal differentiation in the 50 µm microchannels similar to β-tubulin-
III staining. The neurite length determined from MAP2 positive cells was found to be 
mostly comparable to the control at the same week, consistent with the results from β-
tubulin-III staining (Figure 3.10D). However, the number of neurites in the MAP2 
stained samples was not large enough to carry out ANOVA analysis (groups labeled with 
NA below brackets). The comparable staining results of MAP2 and β-tubulin-III support 
our method of identifying differentiated neuronal cells by β-tubulin-III staining.  
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Figure 3.10: C17.2 cells behavior characterized by MAP2 staining. (A) The morphology 
of cells shown as overlaid phase contrast and MAP2 staining images. Green: MAP2. 
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Blue: cell nuclei. Scale bar=50 µm. The insets of MAP2 and cell nuclei staining were 
from the boxed region and were at the same scale as the main images. (B) MAP2 and β-
tubulin-III (gray shades) positive cell counts per mm2 over three weeks. Both staining 
showed similar trend of cell differentiation versus test conditions. (C) The neuronal cell 
count per mm2 over time determined by cell morphology plus MAP2 or β-tubulin-III 
(gray shades) staining. (D) The average neurite length per mm2 over time with positive 
MAP-2 or -tubulin-III (gray shades) staining. The controls (with “cM” for MAP2 
control and “cβ” for β-tubulin-III control) were C17.2 NSCs seeded at the same surface 
density in FluoroDishes but without microchannels and fed every 48 hours as in standard 
subculture protocols. Bars with “O” in Figure C and Figure D indicated that no cell was 
identified as a neuronal cell. Data were shown as mean ± standard deviation. The * above 
the bars indicated a statistical difference between the sample and the control by two-
tailed Student’s t test (p <0.05). The */** below the bars indicated a statistical difference 
in the group by the one-way ANOVA test (p <0.05). The ** in Figure D indicated a 
significant difference due exclusively to the samples with no neurite outgrowth. The 
groups labeled with NA below the brackets did not have enough number of neurites for 
ANOVA analysis. N15. Reprinted with permission from Maintenance and neuronal cell 
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differentiation of neural stem cells C17.2 correlated to medium availability sets design 
criteria in microfluidic systems. 39 Copyright: © 2014 Wang et al. 
3.3.8 Correlation of the MF to Neuronal Cell Differentiation  
To quantify the average amount of medium available to cells over time, the MF was 
introduced, which is the amount of culture medium available to each cell (cell number 
from initial seeding) divided by the feeding interval.  
As summarized in the heat maps in Figure 3.11, experiment groups with low MFs (top 
right corner of each graph) were often associated with more prominent neuronal cell 
differentiation marked by more cells with positive β-tubulin-III staining (red) and more 
neuronal cells (green) than groups with high MFs (lower left corner of each graph). The 
neurite length is mostly ~100 m except for those without observable neurite outgrowth 
(marked with a cross in the last panel of Figure 3.11). 
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Figure 3.11: Summary of cell phenotypes with microchannel heights of 50 µm to 1000 
µm and feeding frequencies of 12 hours to 48 hours. Groups with small MFs (towards top 
right corner of each graph) generally had more obvious neuronal cell differentiation as 
demonstrated by brighter colors representing higher density of cells with positive β-
tubulin-III staining and neural morphology (first and second columns). The neurite length 
(third column), however, did not seem to have a strong correlation with the MF. The 
samples without noticeable neurite outgrowth were marked with a cross sign. Reprinted 
with permission from Maintenance and neuronal cell differentiation of neural stem cells 
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C17.2 correlated to medium availability sets design criteria in microfluidic systems. 32 
Copyright: © 2014 Wang et al. 
 
Figure 3.12: Correlation between MF and neuronal cell differentiation. (A) Samples with 
MF number smaller than 8.3  104 μm3/cellhour had significantly higher numbers of β-
tubulin-III positive cells than that of the control. Samples with MF numbers equal to or 
larger than 8.3  104 μm3/cellhour had similar β-tubulin-III positive cell population 
compared to the control. (B) Samples with MFs smaller than 8.3  104 μm3/cellhour 
generally had significantly higher numbers of neuronal cells while samples with MFs 
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equal to or larger than 8.3  104 μm3/cellhour were mostly comparable to the control. (C) 
The average neurite length had minimal correlation with the MF. The control (with “c”) 
was C17.2 NSCs seeded at the same surface density in FluoroDishes but without 
microchannels and fed every 48 hours as in standard subculture protocols. In all data 
points, N15. * indicates statistical difference compared to the control after 1 week, ** 
for 2 weeks and *** for 3 weeks (p < 0.05). The vertical dash line represents the critical 
MF of 8.3  104 μm3/cellhour. Reprinted with permission from Maintenance and 
neuronal cell differentiation of neural stem cells C17.2 correlated to medium availability 
sets design criteria in microfluidic systems. 32 Copyright: © 2014 Wang et al. 
Statistical analysis was carried out to quantitatively investigate the correlation between 
MF and neuronal cell differentiation. MF values of all experiment groups were calculated 
and data sets were re-organized based on their MF values. As shown from the relatively 
tight error bars in most data points in Figure 3.12, the parameter MF is the dictating 
factor that controls the behavior of C17.2 in standard culture media. The critical MF of 
8.3  104 μm3/cellhr is indicated by the vertical dash line in Figure 8. The control is 
labeled with “c”. Demonstrated in Figure 3.12A, samples with MF smaller than 8.3  104 
μm3/cellhr had significantly larger numbers of β-tubulin-III positive cells than that of the 
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control (p values range from 7  10-15 to 0.0004). Samples with MF numbers equal or 
greater than 8.3  104 μm3/cellhr had similar β-tubulin-III positive cell population 
compared to the control (p values range from 0.1 to 0.8). This correlation held true over 
the entire experiment course of 3 weeks (* indicates statistical difference compared to the 
control after 1 week, ** for 2 weeks and *** for 3 weeks). The number of neuronal cells 
also correlated well with the MF (Figure 3.12B). Samples with MFs smaller than 8.3  
104 μm3/cellhr generally had significantly higher numbers of neuronal cells (p range 
from 5  10-13 to 0.013) while samples with MF equal to or greater than 8.3  104 
μm3/cellhr were comparable (p values range from 0.1 to 1) to the control. Out of 24 data 
sets, only 2 fell out of this correlation, i.e. at MF=41,500 μm3/cellhr at week 1 (p=0.28) 
and MF=8,300 μm3/cellhr at week 3 (p=0.9). These two outliers were likely a result of 
time-dependent uprising and degeneration of the neuronal cell population over time. 
When further examining the morphological change of cells over time, an almost pure 
neuronal cell population of high density was observed at week two for groups with MF of 
8.3  103 μm3/cellhr or smaller. On the other hand, the average neurite length mostly 
remained unchanged with the MF (Figure 3.12C) regardless of the level of spontaneous 
differentiation. Thus, the MF is a parameter that can be used to predict spontaneous 
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neuronal cell differentiation in standard culture medium for C17.2 NSCs, while the 
neurite length is not strongly controlled by the MF.  
While the microfluidic culture introduced a few differences from conventional culture, 
including the exposure to shear stress, presence of PDMS and rate of nutrient depletion, 
the nutrient availability seemed to be the main contributor to the observed spontaneous 
differentiation. In our preliminary studies of short term culture, we demonstrated that 
leachant from PDMS, if present, did not induce higher C17.2 differentiation than the 
control of conventional culture. In addition, the optimal shear stress to maintain C17.2 
NSCs was found to be around 0.004 Pa. This shear stress is within the range normally 
experienced by NSCs in vivo. 142 NSCs in their natural physiological environment 
experience shear stress generated by interstitial flow, which falls into the range of 0.01 to 
0.001Pa. 142–144,148–150 Thus the flow condition used in the study is not expected to be 
detrimental to the NSCs. C17.2 cells cultured in the 2mm-thick channel showed 
comparable or even lower spontaneous differentiation when compared to the 
conventional static culture, indicating the shear condition used here did not contribute to 
the enhanced differentiation in the thinner channels. Thus, the correlation of the cell 
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phenotype with the MF demonstrates that MF is the major contributor to the observed 
high levels of spontaneous differentiation in thin devices or long feeding intervals. 
Our observation of spontaneous neuronal cell differentiation under low MF is consistent 
with reports in the literature from in vivo studies: in response to nutrient depletion and the 
resulting damage in the neural network, NSCs go through neuronal cell differentiation in 
an effort to repair the damage. 86,96,97,124–129 Nutrient depletion by serum withdrawal is 
also the predominant method to induce neuronal differentiation of C17.2 NSCs in vitro. 
130–132,141,151  
Although it is difficult to predict or determine the molecular source that contributes to the 
process, the observed critical MF suggests that the key molecules should have been 
consumed and reached a critically low concentration to induce spontaneous 
differentiation. For example, epidermal growth factor (EGF) may be an important player 
in neuronal cell differentiation: stem cell culture medium contains 10 ng/ml EGF while 
differentiation medium contains no EGF. 95,152–156 Based on the MF threshold, the 
consumption rate of EGF is predicted to be greater than 3.5  10-23 mol/scell. This 
prediction is consistent with experimental measurements that places consumption rate of 
EGF at 3.4  10-22 mol/scell for a fast EGF consuming cell model A431 epidermoid 
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carcinoma cells. 157 Thus, the MF threshold identified here may offer insight about the 
consumption rates of key chemicals involved in neuronal cell differentiation.  
As observed in all the samples showing NSC differentiation, the neuronal cell population 
experienced a dynamic process of growth, peak and degeneration over the 3 week culture 
period. Although neurons are terminally differentiated cells and cannot proliferate, 158–162 
primary neurons are capable of surviving in vitro culture for weeks. 32,120,147 The fast 
degeneration of the spontaneously differentiated neuronal cells in the case described 
herein may be caused by two possible reasons: an unfavorable environment to maintain 
neuronal cells and lack of an integrated neuronal cell network that is often required for 
long-term neuronal survival in vitro. The culture medium and feeding pattern was 
optimized for culturing NSCs instead of neuronal cells. Although neuronal cells can 
differentiate spontaneously from NSCs through nutrient consumption, maintaining them 
might require medium adjustment as neural apoptosis can be induced by a variety of 
stimuli such as growth factor concentration change and glucose concentration change. 163–
172 Additionally, neurons are much more sensitive to shear stress than NSCs, thus cell 
feeding through laminar flow may damage the neuronal cells. 32,43,120,156,173–177 The other 
possible cause is immaturity of neural network. The protocols to induce NSC 
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differentiation (C17.2 cells and others) and maintain the resulting neuronal cells usually 
require chemical stimuli concurrent with nutrient depletion. 86,92,130–132,139,141,154,178 These 
stimuli promote the formation of dopaminergic neurons and neural communication, 
which are key to their integration in certain areas of the brain. 84–87,92,94,97,161 The neuronal 
cells formed in this study by nutrient consumption alone may lack the proper cues to 
integrate into a network, thus degenerate soon after differentiation.  
While the cell population and nutrient availability are widely different in this study, the 
neurite outgrowth length appears consistent in majority of the test conditions. It has been 
reported that when using the same differentiation method, the length of neurites is 
characteristic of the physical environment. Curley et al. have reported characteristic 
neurite length of differentiated C17.2 NSCs on materials of different elasticity. 179 Yang 
et al. have used complex environmental physical cues to control both the neurite length 
and orientation of differentiated C17.2 NSCs. 180 The consistency of neurite outgrowth 
length observed in this study is likely a result of comparable physical exposures in all 
microfluidic samples, while the biochemical cues from nutrient restriction don’t seem to 
play a key in neurite development after initiating NSC differentiation.  
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Despite the observed degeneration of differentiated neuronal cells, the β-tubulin-III 
positive cell population generally maintained a steady growth in our study, even after 
neuronal degeneration. This was a result of an emerging cell population with flattened 
morphology and multiple radially extended unbranched short processes in week 3. These 
morphological characteristics are consistent with those of intermediate cell types between 
NSCs and neurons. 181,182 While β-tubulin-III is often used an early neural marker, 183–185 
any neuron-restricted progenitor cell type between the NSC phase and differentiated post-
mitotic neuron phase could express β-tubulin-III. 186–188 The continuous proliferation of 
the intermediate cells kept the β-tubulin-III positive cell on the rise, 155,181,189–193 however, 
they were incapable of replacing the degenerated neuronal cells in the culture 
environment studied here. Our observation suggests different signals and culture 
environments may be required for the branched differentiation pathways from C17.2 
NSCs to neuronal cells and from intermediate cells to neuronal cells.  
3.4 Conclusions  
The optimum conditions including substrate chemistry and flow conditions to maintain 
C17.2 NSC culture in microfluids has been determined by short term culture. Exposure to 
long term periodic shear stress in microfluidics does not induce neural differentiation of 
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C17.2 NSC. The MF successfully predicts the outcome of C17.2 NSCs in standard 
culture medium. The MF smaller than 8.3  104 μm3/cellhour causes spontaneous 
neuronal cell differentiation marked by a higher density of cells with positive β-tubulin-
III or MAP2 staining and neural morphology than the control. On the other hand, 
minimal spontaneous neuronal cell differentiation is observed when the MF is equal to or 
larger than 8.3  104 μm3/cellhour. The average neurite length does not have a strong 
correlation with the MF. The MF can be controlled by several experimental factors such 
as cell density, cell medium volume and feeding time interval to maintain the stem cell 
status of C17.2 NSCs or to induce various levels of neuronal cell differentiation. Thus, 
the findings offer guidelines to microfluidic system design for controllable NSC 
maintenance and differentiation.   
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Chapter 4 
Enhancement of Surface Binding by Laser 
Heating Induced Mass Transport 
4.1. Motivation 
Specific and efficient interactions between analyte and an affinity surface are key to the 
performance of biosensors and microarrays. 194–198 Many microsensors utilize diffusion as 
the sole transport mechanism and analyte consumption by the surface reaction can 
dominate diffusive feeding, resulting in diffusion limited reactions. To overcome this 
limit and improve the rate and equilibrium level of surface binding, various strategies 
have been devised to improve the mass transport. Continuous feeding is a popular option 
to replenish analyte near the capture bed when it can be afforded. 55,199,200 For example, 
Squires et al. compared the performance characteristics of biosensors with and without 
tangential flow and found faster sensor saturation with advection. 201 Yanik et al. 
modeled mass transport by flow to a nanohole based plasmonic sensor and discovered 
that a 14-fold improvement over diffusive transport would compensate reaction induced 
depletion zones. 202 However, continuous feeding generally consumes a lot of analyte and 
is not be applicable for precious samples. Alternatively, Hart et al. used AC 
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electroosmosis to increase mass flux to an IgG detector and observed an enhancement of 
fluorescent antibody binding up to 6.7 times, along with a reduction of reaction 
equilibrium time by up to a factor of 6. 203 Sigurdson et al. obtained a 7 fold sensitivity 
increase in an antibody sensor by electrothermal stirring. 204 However, these methods 
require patterned electrodes and risk potential electrochemical reactions at the electrode-
solution interface. Enhanced mass transport and local concentration enhancement has 
also been achieved using acoustic radiation pressure. This method offers the flexibility of 
instantly changing the accumulation location, but suffers from the requirement of 
elaborate device fabrication. 205 Optical tweezers have been shown to enhance analyte 
concentration next to a biosensor by several orders of magnitude, but biomolecules and 
nano-vesicles often don’t have considerable refractive index difference from the 
surrounding solution necessary for efficient tweezing. 206,207 
Recently, a number of research papers reported molecular accumulation in a solution 
driven by a temperature gradient. 208–211 The phenomena has been proposed as plausible 
mechanism to explain the origin of life, 211 and has been used to study colloid interfacial 
thermodynamics and biomolecule interactions. 209,212 The temperature gradient generates 
two transport effects in addition to diffusion: thermophoresis of solutes along or against 
105 
 
the temperature gradient and recirculation by natural advection. Together, the three 
transport processes create a non-uniform concentration distribution, and the concentration 
factor is controllable by the Soret coefficient, temperature gradient and reactor geometry. 
208 Inspired by these studies, this work explores if a mild temperature gradient can 
enhance binding of ligand on an affinity surface. Compared to other methods, 
temperature gradients can be imposed on a reaction chamber remotely, saving the effort 
to fabricate electrodes and actuators into the reactor. Furthermore, a mild temperature 
range of 0-37C is compatible with biological samples. 212,213 Compared to continuous 
feeding of analyte, temperature gradients induce recirculation and promote mass transport 
without wasting precious samples.  
Various strategies have been implemented to create temperature gradients. Miniaturized 
vessels are often used to promote a strong gradient with a mild temperature variation. 
Mao et al. generated a linear temperature gradient across microfluidic channels by 
placing them between hot and cold water reservoirs. 214 Guijt et al. used endothermic and 
exothermic reactions as the heat source and drain. 215 However, the temperature gradient 
is gentle in these setups due to a significant temperature drop in the vessel walls. It is also 
challenging to maintain a temporal stability of the gradient in the later setup as the heat 
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source and sink equilibrate. Joule heating has been shown to offer more precise spatial 
and temporal control of temperature. 216 For example, Vigolo et al. encapsulated silver in 
the epoxy wall of a microvessel for resistive heating. 217 Although the temperature 
gradient is stable and adjustable, the device fabrication is complicated. Recently, Braun 
and Libchaber reported the use of a laser to generate temperature gradients in 
microchambers. This setup allows remote temperature control with precision spatial and 
temporal resolution, requires no fabrication in the microchamber itself and is compatible 
with in situ optical microscopy. 210,216 Given these advantages, we employed laser heating 
in a microchamber for transport enhancement and studied affinity binding on the 
functionalized floor. COMSOL simulations and dimensional analysis were used first to 
reveal the contribution of different transport processes on the surface binding kinetics and 
steady state surface concentration. Afterwards, the binding of biotinylated nanoparticles 
to NeutrAvidin-immobilized substrates were studied experimentally to validate the 
improvement predicted by the computational analysis. 218,219  
4.2. Materials and Methods 
4.2.1 Simulation of Surface Binding  
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Two-dimensional simulations were performed using COMSOL Multiphysics software, a 
commercial finite element package (COMSOL Inc., Burlington, MA). The dimension of 
the microwell and the starting bulk concentration of nanoparticles were varied as listed in 
Table 4.1.  
Starting bulk concentration (nM) 0.05, 0.5, 5 
Width of microwell (µm) 100, 200, 300, 400, 500 
Height of microwell (µm) 5, 15, 50, 150, 300, 500 
Table 4.1. List of variables used in the COMSOL simulation  
For the simple case of surface reactions without a temperature gradient, the analyte 
diffusivity was set to be 1.4 × 10−12 𝑚2/𝑠, corresponding to diffusivity of nanoparticles 
used in the experiments (Supplemental I). The density and viscosity parameters of water 
at 293 K were selected from the COMSOL materials library. Using the Surface Reactions 
module, surface binding was stimulated as a second-order reaction with a forward rate 
constant 𝑘𝑓 = 2 × 10
5 𝑚3/𝑚𝑜𝑙 ∙ 𝑠, a value corresponding to the biotin and NeutrAvidin 
interaction. 220 The reverse rate constant for the NeutrAvidin-Biotin interaction is 4 ×
10−4 /𝑠, which is small and was neglected. 220 A lower 𝑘𝑓 = 1 𝑚
3/𝑚𝑜𝑙 ∙ 𝑠 was used in 
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a few cases to demonstrate slow surface reactions and these cases are noted in the paper. 
The bulk concentration of analyte at t = 0 was varied from 0.05 nM to 5 nM (consistent 
with the detection range of most ELISA kits), and the density of surface binding sites at t 
= 0 was fixed at 1 × 10−8 𝑚𝑜𝑙/𝑚2. 221  
To simulate surface binding in microwells with a temperature gradient, the Heat Transfer 
in Solids module was used and temperature at the top center of the microwell was set at 
303 K. The sidewalls and floor of the microwell were set at room temperature of 293 K. 
Thermophoresis was simulated using codes from Braun et al. with the Coefficient Form 
PDE module. 210 The thermodiffusion coefficient for the analyte, DT, was set at 7 ×
10−13 𝑚2/𝑠 ∙ 𝐾 according to the literature for polystyrene beads. 208 The Laminar Flow 
module was used to simulate heat induced advection. Parameters (density, heat capacity, 
viscosity and thermal conductivity) of water were selected from the COMSOL materials 
library. The surface reaction was set up the same way as described above using the 
Surface Reactions module. 
In both simulation setups, mass flux at the boundaries were set to be zero except for the 
reaction surface where reacted bulk species became surface species.  
4.2.2 Dimensional Analysis  
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Dimensional analysis was carried out to understand relationships between different 
transport processes and their contributions to the surface reaction. The dominant transport 
mechanism among diffusion, advection and thermophoresis was analyzed first as a 
function of microwell dimension and analyte concentration. Afterwards, the transport 
flux to the reactive surface was compared to drain from the surface reaction. It was 
assumed in the analysis that surface reaction equilibrated slowly enough that bulk 
depletion evolved quasi-steadily, i.e. the mass transport could be described by a steady-
state flux.  
4.2.2.1 Dimensional Analysis of Transport Processes: Three mass transport processes 
were considered in this work in the presence of a temperature gradient: normal diffusion, 
natural advection and thermophoresis. The diffusive flux is defined as 𝐽𝐷 = −𝐷∇𝐶. For 
scaling purposes, the gradient ∇𝐶 was approximated as a change in concentration 
divided by the distance d over which it changed. As the floor was uniformly reactive and 
the microwell height H was much less than the width W in most cases, d was on the order 
of H. Assuming that the targets were instantly captured upon encountering the surface 
and remained bound indefinitely, the concentration change was from 𝐶0 in the bulk to a 
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near-surface concentration of 0.  Thus, we obtained the diffusive flux 𝐽𝐷~𝐶0𝐷/𝐻 and 
characteristic diffusion time 𝛿𝐷~𝐻
2/𝐷. 
For natural advection driven by the temperature gradient, the advective flux  𝐽𝐴~𝐶0𝑢, 
where 𝑢 is the average magnitude of velocity of natural advection. The value 𝑢 was 
extracted from COMSOL simulation in this work. The characteristic advection time was 
calculated as 𝛿𝐴~𝐻/𝑢, since microwell height H was much less than the width W in 
most cases, and was used as the characteristic length. 
The thermophoretic flux is defined as 𝐽𝑇 = 𝐶𝐷𝑇∇𝑇. With the shallow and relatively wide 
microchamber dimension, the temperature difference of ∆𝑇 dropped over a length scale 
on the order of 𝐻, so that the initial thermophoretic flux  𝐽𝑇~𝐶0𝐷𝑇∆𝑇/𝐻 and the 
characteristic thermophoresis time 𝛿𝑇~𝐻
2/𝐷𝑇∆𝑇. 
Three non-dimensional parameters comparing the transport processes were defined as 
below: 
𝑃𝑒𝑎𝑑𝑣/𝑑𝑖𝑓𝑓 =
𝐴𝑑𝑣𝑒𝑐𝑡𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
𝐷𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
= 
𝛿𝐷
𝛿𝐴
= 𝐻𝑢/𝐷 
𝑅𝑡ℎ𝑒𝑟𝑚/𝑑𝑖𝑓𝑓 =
𝑇ℎ𝑒𝑟𝑚𝑜𝑝ℎ𝑜𝑟𝑒𝑡𝑖𝑐 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
𝐷𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
= 
𝛿𝐷
𝛿𝑇
= 𝐷𝑇∆𝑇/𝐷 
𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 =
𝐴𝑑𝑣𝑒𝑐𝑡𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
𝑇ℎ𝑒𝑟𝑚𝑜𝑝ℎ𝑜𝑟𝑒𝑡𝑖𝑐 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
= 
𝛿𝑇
𝛿𝐴
= 𝐻𝑢/𝐷𝑇∆𝑇 
111 
 
In the absence of a temperature gradient, analyte were transported to the reactive surface 
by diffusion only. The enhanced transport in the presence of a temperature gradient was 
expressed as:  
𝑅(𝑡ℎ𝑒𝑟𝑚+𝑎𝑑𝑣)/𝑑𝑖𝑓𝑓 =
𝑇ℎ𝑒𝑟𝑚𝑜𝑝ℎ𝑜𝑟𝑒𝑡𝑖𝑐 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒+𝐴𝑑𝑣𝑒𝑐𝑡𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
𝐷𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
  
=
𝛿𝐷
𝛿𝐴
+
𝛿𝐷
𝛿𝑇
= (𝐻𝑢 + 𝐷𝑇∆𝑇)/𝐷  
4.2.2.3 Dimensional Analysis of Transports and Surface Reactions: For the reaction 
of analyte binding to an affinity surface, the reactive flux can be written as: 
𝐽𝑅 = 𝑘𝑓𝑏𝐶 − 𝑘𝑟𝐶𝑆  
where the forward rate constant is 𝑘𝑓, reverse rate constant is 𝑘𝑟, concentration of 
unreacted surface binding sites is 𝑏, bulk concentration is 𝐶 and the concentration of 
surface species is 𝐶𝑆. Given the high affinity of the simulated receptor-ligand pair, 
desorption was neglected. The reactive flux was simplified to 𝐽𝑅 = 𝑘𝑓𝑏𝐶. For scaling 
purposes, the initial reactive flux  𝐽𝑅~𝑘𝑓𝑏0𝐶0 and the characteristic reaction time 
𝛿𝑅~𝐻/𝑘𝑓𝑏0. 
In the microwell with a uniform temperature, the Damköhler number was calculated as: 
𝐷𝑎 =
𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑒
𝐷𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑒 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
=
𝛿𝐷
𝛿𝑅
= 𝑘𝑓𝑏0𝐻/𝐷  
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In the microwell with a temperature gradient: 
 𝐷𝑎 =
𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛 𝑅𝑎𝑡𝑒
𝐶𝑜𝑚𝑏𝑖𝑛𝑒𝑑 𝑇𝑟𝑎𝑛𝑠𝑝𝑜𝑟𝑡 𝑅𝑎𝑡𝑒
=
1
𝛿𝑅(1/𝛿𝐷+1/𝛿𝐴+1/𝛿𝑇)
= 𝑘𝑓𝑏0𝐻/(𝐷 + 𝐻𝑢 + 𝐷𝑇∆𝑇) 
4.2.3 Experimental Setup 
The experiments were carried out on a modified confocal microscope (Olympus, PA). 
The microchamber has a dimension of 50 µm × 5 mm × 5 mm. An IR laser (1064 nm) 
was introduced above the sample and was focused on the ceiling. The temperature 
gradient was calibrated using 50 mM 2',7'-bis-(2-carboxyethyl)-5-(and-6)-
carboxyfluorescein (BCECF, Life Technologies, CA) in a 10 mM Tris buffer (Sigma 
Aldrich, WI). The fluorescence intensity of BCECF drops by 2.8% in response to an 
increase of 1 K in temperature. 208,211,222 The temperature calibration was carried out by 
changing the input laser power and recording the corresponding fluorescence intensity on 
the ceiling as shown in Supplementary II: Temperature calibration. Images in all 
experiments were processed by software FV-10-ASW (Olympus, PA) and analyzed by 
ImageJ (National Institutes of Health).  
4.2.3.1 Microwell Fabrication and Surface Treatment  
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A mixture of PDMS prepolymer and curing agent at a weight ratio of 10:1 (Sylgard 184, 
Dow-Corning, MI) was spin-coated on a coverslip (2” × 3”, thickness #1, Ted Pella, CA) 
at 500 rpm for 5 min. The resulting PDMS film of 50 µm thickness was cured on the 
coverslips at 65-75 °C overnight, and a square hole was cut in PDMS to create a 50 µm × 
5 mm × 5 mm reaction chamber. 
To functionalize the floor of the microwell, the devices were activated by oxygen plasma 
and submerged sequentially in the following solutions: 4% (v/v) solution of 3-
mercaptopropyl trimethoxysilane (Gelest, PA) in ethanol for 1 hour at room temperature, 
0.01 μmol/mL N-gamma-Maleimidobutyryl-oxysulfosuccinimide ester (GMBS, Pierce 
Protein, IL) in ethanol for 1 hour at room temperature, and finally 10 μg/mL NeutrAvidin 
(Pierce Protein, IL) in phosphate buffered saline (PBS, Sigma Aldrich, WI) for at least 1 
h at 4 oC. Immediately before use, the microwells were blocked by 1% (w/v) bovine 
serum albumin (BSA, Sigma Aldrich, WI) in PBS for at least 15 min and blot dry. The 
control devices were functionalized similarly except for 0 μg/mL NeutrAvidin in PBS.  
4.2.3.2 Calibration of Fluorescence Intensity from Surface Binding  
AF488- biotin -labeled polystyrene nanoparticles (Life Technologies, CA) 200 nm in 
diameter were suspended in deionized water, sonicated for 20 min in an ice water bath 
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and used immediately. To yield a proper range of surface nanoparticles density for 
calibration, nanoparticles suspensions of 0.004, 0.013, 0.04, 0.13 and 0.4 nM were used. 
Two microliter of nanoparticles suspension was pipetted into the functionalized 
microwell, and the microwell was capped with a coverslip (1” × 1”, Fisher Scientific, 
PA). The surface of the coverslip in contact with the suspension was coated with 200 nm 
chromium to mimic the condition used in the temperature gradient experiments. The 
nanoparticle suspension was allowed to react in the microwell for 75 minutes and the 
fluorescence intensity on the microwell floor was recorded using a confocal microscope. 
Afterwards the microwell was washed 3 times with deionized water, air dried and coated 
with iridium for scanning electron microscope (SEM) imaging. The number of 
nanoparticles per unit area (100 µm2) was counted from the SEM images. Non-specific 
binding was characterized using BSA passivated microwells without NeutrAvidin and 
nanoparticles at a concentration of 0.04 nM. For each condition, 3 samples were used for 
repeats; for each sample, 3 images were taken at random locations for both the 
fluorescence and SEM measurements. All data sets in graphs are presented as average ± 
standard deviation from 9 data points.  
4.2.3.3 Kinetics of Surface Binding without Temperature Gradients 
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To monitor the kinetics of surface binding without a temperature gradient, 2 L of the 
nanoparticle suspension at 0.04 nM was allowed to react in a microwell covered by a 
chromium coated coverslip. The fluorescence intensity at the microwell floor was 
recorded every 5 minutes until the reaction reached a steady state. Then the average 
fluorescence intensity in each frame was converted to a surface concentration using the 
calibration curve described above. For each condition, 3 samples were used for repeats. 
All data sets in graphs are presented as average ± standard deviation from 3 repeats.  
4.2.3.4 Kinetics of Surface Binding with Temperature Gradients  
To record the kinetics of surface binding with a temperature gradient, 2 L of the 
nanoparticle suspension at 0.04 nM was pipetted into a functionalized microwell. 
Immediately after capping the microwell with a chromium-coated coverslip, an IR laser 
(1064nm) was focused on the chromium ceiling to generate local heating 10K above 
room temperature. The fluorescence intensity on the microwell floor was recorded every 
5 min until the reaction reached a steady state. To analyze the resulting accumulation 
ring, the radially distributed fluorescence intensity was measured. Since the highest 
intensity usually occurred at 20-30 µm from the center, fluorescence intensity from this 
region was averaged to obtain maximum surface binding. To verify that the accumulation 
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ring was from surface binding rather than physical accumulation in the bulk, the heating 
laser was turned off after the reaction completed. The fluorescence intensity profile 
showed a minimal change, which confirmed that the particles were not free to diffuse 
anymore and were surface-bound. For each condition, 3-5 samples were used for repeats. 
All data sets in graphs are presented as average ± standard deviation from more than 3 
repeats.  
4.3. Results and Discussion 
Figure 4.1 shows the COMSOL simulation result of a microwell with 5 mm × 5 mm 
footprint and various well heights (5 µm, 15 µm, 50 µm, 150 µm, 300 µm to 500 µm) 
used for the capture of 200 nm nanoparticles. The bulk concentration of nanoparticles and 
surface concentration of receptors are the same in all cases at t=0, and the surface 
receptor concentration is sufficient to deplete all nanoparticles even in the deepest 
microwell studied here of 500 µm. Reaction rate constants corresponding to the 
NeutrAvidin-biotin pair are used. Figure 4.1A demonstrates the binding kinetics on the 
surface: to account for the difference in the total amount of analyte available, the surface 
concentration is normalized to the height of microwells. As the reverse rate constant is 
negligible for the NeutrAvidin-biotin reaction, all reactions reach equilibrium when the 
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analyte is exhausted in the microwells. The height normalized surface concentration thus 
all plateaus at the same level. The reaction half-life (time required for the surface 
concentration to reach half of the equilibrium concentration) is then extracted and plotted 
against the microwell heights in Figure 4.1B (dots). As the height of the microwells 
increases stepwise from 5 µm to 500 µm, the reaction half-life increases significantly 
from 6 s to 12 hrs. The half-life scales with the square of the microwell heights (line in 
Figure 4.1B), and the prefactor is on the same order as 1/2𝐷, with D being the diffusion 
coefficient of the analyte. Since the microwell height is the characteristic length in most 
geometries studied here (wide and shallow wells), this relationship suggests that surface 
binding is diffusion limited despite microscale reactions. Diffusion limited reactions are 
also confirmed by dimensional analysis of the Damköhler number, which is on the order 
of 103 to 105 for the different chamber heights studied here.    
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Figure 4.1: COMSOL simulation of binding of biotinylated 200 nm nanoparticles to 
surface immobilized NeutrAvidin in microwells with footprints of 500 µm × 500 µm and 
heights of 5 µm, 15 µm, 50 µm, 150 µm, 300 µm and 500 µm respectively. (A) Surface 
binding kinetics normalized to the height of microwells show a red shift with the depth of 
the microwells. (B) The reaction half-life (time required for the surface concentration to 
reach half of the equilibrium concentration, plotted as dots) scales with the square of the 
microwell height (solid line), suggesting the reactions are diffusion limited.  
To overcome the diffusion limit, we introduce a temperature gradient to the reaction 
reservoir, which creates two additional transport processes, thermophoretic migration of 
the analyte and natural advection. In the COMSOL simulation, temperature at the center 
of the microwell ceiling is set at 303 K, 10 K higher than the ambient of 293 K. We first 
examined the dependence of natural advection on the microwell heights (5 µm, 15 µm, 
50 µm, 150 µm, 300 µm and 500 µm while the width is fixed at 500 µm) and widths (100 
µm, 200 µm, 300 µm, 400 µm and 500 µm while the height is fixed at 50 µm). As shown 
in Figure 4.2A, the average velocity of advection increases mildly from 5.3 × 10-8 m/s 
to 1.9 × 10-7 m/s as the width of the microwells increases from 100 µm to 500 µm, 
indicating limited benefit to mass transport. On the other hand, the average velocity 
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changes dramatically from 1.2 × 10-11 m/s to 1.3 × 10-5 m/s as the height of the 
microwells increase from 5 µm to 500 µm (Figure 4.2B). This is understandable since 
the Rayleigh number scales with the cube of the characteristic length. In our study where 
the height of the microwell is never larger than the width of the microwell, the 
characteristic length is mostly controlled by the height.  
 
Figure 4.2: COMSOL simulation of average velocity in microwells with various widths 
and heights. (A) The average velocity in microwells with a fixed height of 50 µm, but 
varied footprint widths of 100 µm, 200 µm, 300 µm, 400 µm and 500 µm respectively. 
Mild increases in velocity indicate limited benefits to mass transport. (B) The average 
velocity in microwell with a fixed footprint width of 500 µm but varied heights of 5 µm, 
15 µm, 50 µm, 150 µm, 300 µm and 500 µm. Significant changes in velocity indicate a 
pronounced benefit to convective mass transport. 
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In addition to controlling the magnitude of natural advection, the microwell height also 
influences the temperature gradient, which drives thermophoresis of analyte to the 
reactive surface. Since the microwell height is much less than the width in most cases, 
and the glass floor has much higher heat conductivity than water, the microwell height is 
considered the characteristic length for temperature gradient scaling. The thermophoretic 
flux to the reactive surface scales linearly with the temperature gradient, while the later 
decreases with the chamber height. Thus, the thermophoretic and advective fluxes have 
opposite dependence on the chamber height.   
To compute the relative contribution of the three transport processes, ratios of the 
transport rates are calculated and shown in Figure 4.3A as a function of microwell 
heights and average advective velocities. 𝑃𝑒𝑎𝑑𝑣/𝑑𝑖𝑓𝑓 represents the ratio of advective 
transport rate relative to diffusive transport rate; 𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 represents advective 
transport rate relative to thermophoretic rate; 𝑅𝑡ℎ𝑒𝑟𝑚/𝑑𝑖𝑓𝑓 represents thermophoretic rate 
relative to diffusive transport rate. 𝑅(𝑡ℎ𝑒𝑟𝑚+𝑎𝑑𝑣) 𝑑𝑖𝑓𝑓⁄  represents the combined transport 
rate driven by the temperature gradient (thermophoresis and natural advection) relative to 
diffusive on transport rate. The temperature gradient is found to promote transport in all 
geometries (𝑅(𝑡ℎ𝑒𝑟𝑚+𝑎𝑑𝑣) 𝑑𝑖𝑓𝑓⁄ > 1). The enhanced transport is initially contributed 
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predominantly by thermophoresis (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 < 1 when 𝐻 < 60 µm) and later by 
natural advection (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 ≥ 1  when 𝐻 ≥ 60 µm). In the advection dominant 
region, 𝑅(𝑡ℎ𝑒𝑟𝑚+𝑎𝑑𝑣) 𝑑𝑖𝑓𝑓⁄  increases dramatically from 151.1 to 4535.7 when the 
microwell height increases from 60 to 500 µm. On the other hand, it remained relatively 
constant (5.0 – 6.9) in the thermophoresis dominated region.  
To compare the reactive flux against the combined transport flux, Damköhler number 
(𝐷𝑎) is presented as a function of microwell heights and advection velocities (Figure 
4.3B). In the absence of the temperature gradient, 𝐷𝑎 increases continuously with the 
microwell height (empty circles). On the other hand, the plot of 𝐷𝑎 versus the microwell 
height demonstrates a bell shape curve when the temperature gradient is present (solid 
dots). This can be interpreted by inspecting the equation derived in the section of 
Dimensional Analysis of Transports and Surface Reactions: 
𝐷𝑎 = 𝑘𝑓𝑏0𝐻/(𝐷 + 𝐻𝑢 + 𝐷𝑇∆𝑇) 
As the microwell height increases, diffusive and thermophoretic fluxes go down but the 
advective flux increases. In the region where thermophoresis dominates or 𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 <
1 (left of the dash line in Figure 4.3B), the combined fluxes by diffusion and 
thermophoresis (relating to term 𝐶0(𝐷/𝐻 +𝐷𝑇∆𝑇/𝐻)) decreases faster than the increase 
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of the advective flux (relating to term 𝐶0𝑢). Therefore a net increase of 𝐷𝑎 is observed. 
In the advection dominated region where 𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 > 1, the opposite is true, leading to 
a rapid drop of 𝐷𝑎. In all cases, 𝐷𝑎 ≫ 1, so the reaction is transport limited even with 
the temperature gradient, but 𝐷𝑎 is reduced by 1 – 4 orders of magnitude compared to 
the uniform temperature reactions (Figure 4.3B, empty dots).  
 
Figure 4.3: Dimensional analysis of transport and reaction fluxes as a function of 
microwell height (top axis) and average advection velocity (bottom axis). (A) 
Dimensionless groups characterizing the transport processes. 𝑃𝑒𝑎𝑑𝑣/𝑑𝑖𝑓𝑓 is the ratio of 
advective transport rate relative to diffusion transport rate; 𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 is the advective 
transport rate relative to thermophoretic transport rate; 𝑅𝑡ℎ𝑒𝑟𝑚/𝑑𝑖𝑓𝑓 is the 
thermophoretic transport rate relative to diffusion transport rate; 𝑅(𝑡ℎ𝑒𝑟𝑚+𝑎𝑑𝑣) 𝑑𝑖𝑓𝑓⁄  is the 
combined transport rate driven by the temperature gradient (thermophoresis and natural 
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advection) relative to diffusion transport rate. The dash line indicates a ratio of 1. (B) The 
Damköhler number 𝐷𝑎 measuring the reaction rate relative to the combined transport 
rate.  In the presence of the temperature gradient, a bell shape curve is observed, while a 
monotonic increase of 𝐷𝑎 with the microwell height is seen without the temperature 
gradient.  
As a result of transport enhancement by the temperature gradient, the reaction rate and 
maximum surface binding are improved (Figure 4.4). When thermophoresis is the 
dominating transport mechanism (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 < 1, 𝐻 < 60µm), the half-life is reduced 
by ~50% compared to reactions with a homogeneous temperature (Figure 4.4A and 
Figure 4.4B). This is a result of comparable fluxes by thermophoresis and diffusion. In 
the advection dominated region (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 ≥ 1, 𝐻 ≥ 60µm), the half-life of reactions 
with temperature gradients still increases with the chamber height, but at a much slower 
rate than that at a homogeneous temperature. Thus the half-life ratio decreases with the 
chamber height. In the 500 m tall microwell, the half-life is drastically reduced from 12 
hrs to 36 min. Such an improvement of reaction rate is not surprising, since velocity of 
natural convection scales with higher power of the chamber height than diffusion does, 
which significantly reduces the diffusion limit.  
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Furthermore, the temperature gradient leads to uneven distribution of the surface bound 
analyte and an accumulation ring is observed. Figure 4.4C demonstrates a snapshot of 
the simulated concentration distribution in bulk (top of Figure 4.4C) and on the surface 
(bottom of Figure 4.4C) in a 50 µm tall microwell 2 min after the reaction. The color 
corresponds to the concentration. The non-uniform concentration results from a 
combined effect of thermophoresis and advection: (1) Thermophoresis pushes 
nanoparticles away from the heat source and towards the sides and bottom of the 
microwell. (2) Vortices generated by natural convection sweep nanoparticles on the 
microwell floor towards the center. While the fluid recirculates up near the center, the 
particles experience thermophoretic repulsion against the temperature gradient and 
accumulate on the floor. Bulk accumulation of DNA into a ring shape has been observed 
by Braun et al. 210 using a similar setup but no affinity substrate. Such non-uniform bulk 
distribution further translates into analyte enrichment on the surface.   
When the maximum surface concentration at the steady state is normalized to the 
chamber height (Figure 4.4D), the accumulation is found to increase with the chamber 
height in the presence of the temperature gradient. In the absence of the temperature 
gradient, the normalized equilibrium surface concentration remains constant due to 
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uniform surface coverage. As a result, enhancement of surface binding, represented by 
the ratio of maximum surface concentration at the steady state with to without 
temperature gradients (Figure 4.4E), increases steadily with the chamber height.  
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Figure 4.4: Simulated improvements of the reaction rate and steady state surface binding 
by superposing temperature gradients on microwells of various heights. Reaction 
constants corresponding to the NeutrAvidin-biotin pair were used. (A) Half-life of 200nm 
nanobeads reacting with affinity surfaces in microwell with (∇𝑇  0) and without (∇𝑇 =
0) temperature gradients. (B) The ratio of half-lives (half-lives of reactions with the 
temperature gradient divided by those without the temperature gradient) shows 50% 
reduction in the thermophoresis dominated region (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 < 1). The ratio decreases 
with the chamber height in the advection dominated region (𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 > 1).  (C) 
Simulated bulk concentration and surface concentration in a 50 µm tall microwell with a 
10 K temperature elevation at the top center. A warmer color indicates a higher 
concentration. (D) Maximum surface concentration at the steady state normalized by 
microwell heights in microwells with (∇𝑇  0) and without (∇𝑇 = 0) temperature 
gradients. (E) Ratio of the steady state surface concentration maxima with a temperature 
gradient to those without a temperature gradient. Enhancement of steady-state surface 
accumulation is observed with the microwell height. In all graphs, the dashed line 
represents 𝑅𝑎𝑑𝑣/𝑡ℎ𝑒𝑟𝑚 = 1.  
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This surface accumulation becomes even more pronounced when the forward reaction 
rate constant is dropped from 2 × 105 m3/mol ⋅ s, a value corresponding to the 
NeutrAvidin-biotin interaction, to 1 m3/mol ⋅ s. The reverse reaction constant is neglected 
for simplicity and 𝐷𝑎 is 0.045, thus the reaction rate is the limiting step. Figure 4.5A 
and Figure 4.5B show the time course of surface concentration profile in the fast and 
slow reactions, respectively, and the same temperature gradient is present. The fast 
reaction generates an accumulation ring of binding. The depleted center is a result of 
thermophoretic repulsion pushing analyte outwards and fast depletion of analyte before it 
is convected to the center. On the other hand, the slower reaction produces peak 
accumulation in the center and the tight accumulation zone produces significantly higher 
surface accumulation. Figure 54.C shows the kinetic change of the peak surface 
concentration. The surface accumulation initially builds up slower with lower 𝑘𝑓 but 
reaches a much higher level at the steady state. The ratio of the peak surface 
concentration with ∇𝑇  0 to that with ∇𝑇 = 0 at each time point is shown in Figure 5D 
for both slow and fast reactions. The ratio first increases with time in both reactions until 
the reaction with the temperature gradient approaches steady state. Afterwards, the 
surface concentration continues to increase in the microwell with a homogenous 
128 
 
temperature and the ratio starts to decrease. At the steady state, the ratio is > 4 times with 
the slow reaction in contrast to a mere 1.04 with the fast reaction. The much more 
enhanced surface accumulation in the slow reaction is not surprising: the analyte is less 
consumed out of the accumulation zone and natural convection continuous feed 
unreacted analyte to the center. In fact, Braun et al. 210 observed a 13-fold bulk 
accumulation at the steady state when DNA molecules were subjected to a temperature 
gradient of ~0.6K/µm (3 times higher than the value used here), with the thermodiffusion 
coefficient (DT) and Soret coefficient (ST) of DNA being comparable to the value used 
here.  
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Figure 4.5: COMSOL simulation of surface binding with a fast (𝑘𝑓 = 2 × 10
5 𝑚3/𝑚𝑜𝑙 ∙
𝑠) and a slow (𝑘𝑓 = 1 𝑚
3/𝑚𝑜𝑙 ∙ 𝑠) reaction. (A) Radially distributed concentration 
profile using the fast reaction model (𝑘𝑓 =2 × 10
5 m3/mol ⋅ s) at different time points. (B) 
Radially distributed concentration profile using the slow reaction model (𝑘𝑓 =1 m
3/mol ⋅ 
s) at different time points. The depletion zone in the center disappears in the slow 
reaction (B) leading to greater accumulation. (C) Kinetic change of the peak surface 
concentration corresponding to the two forward reaction rate constants under the same 
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temperature gradient. (D) ∇𝑇 enhanced surface binding relative to that under a 
homogeneous temperature. The greatest improvement occurs when the reaction with the 
temperature gradient reaches a steady state.  
The simulation results demonstrate that temperature gradient improves both the surface 
binding rate and maximum surface concentration through enhanced transport. To verify 
the simulated findings, we next carried out experiments using 200 nm biotinylated 
nanoparticles and microwells with a dimension of 5 mm × 5 mm × 50 µm and a 
NeutrAvidin treated floor.   
To quantify the concentration of surface bound species dynamically, fluorescence 
intensity was measured in real time on the floor of microwells using confocal 
microscopy. 210,223–225 The intensity was converted to a surface concentration through a 
calibration curve in Figure 4.6. The calibration curve was generated by allowing 
nanoparticles of various concentrations (0.004, 0.013, 0.04, 0.13 and 0.4 nM) to react in 
functionalized microwells for 75 min without laser heating, followed with measurements 
of fluorescence intensity on the microwell floor and SEM imaging of surface bound 
nanoparticle density. The reaction time is long enough to reach steady state in 50m tall 
chambers. Control samples using 0.04 nM nanoparticles and BSA passivated microwells 
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without NeutrAvidin was also tested to estimate nonspecific binding on the floor. As 
shown in Figure 4.6A, NeutrAvidin functionalized substrates promotes specific targets 
binding, which leads to a measurable increase of the fluorescence intensity. In Figure 
4.6B, the fluorescence intensity shows a linear regression towards the surface 
concentration of nanoparticles with good correlation (𝑅2 = 0.9915). For later 
experiments, 0.04 nM nanoparticles were used to make sure the density of surface bound 
targets is well within the linear detection range.  
 
Figure 4.6: Calibration of the fluorescence intensity. A range of surface concentrations of 
nanoparticles were produced by reactions of nanoparticles at various concentrations with 
NeutrAvidin treated surfaces in microwells. The control was microwells with BSA 
passivation but no NeutrAvidin treatment. (A) Considerable difference is observed in 
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both SEM images (top panel) and fluorescence intensity (bottom panel) when 0.04 nM 
nanoparticles react in a control microwell versus a NeutrAvidin-treated microwell. (B) 
The fluorescence intensity shows a linear regression towards the surface concentration of 
nanoparticles with 𝑅2 = 0.9915. The error bars represent one standard deviation (n=9).  
Next we examined the surface binding kinetics in NeutrAvidin-functionalized microwells 
with and without laser heating. The laser generated a temperature 10 K higher than the 
ambient, confirmed ahead by BCECF fluorescence intensity measurements. The 
fluorescence intensity on the microwell floor due to nanoparticle binding was recorded 
every 5 min. The calibration curve in Figure 4.6 was used to convert the intensity to a 
surface concentration. As shown in Figure 4.7A, the temperature gradient produces an 
accumulation ring on the microwell floor, consistent with the simulation prediction in 
Figure 4.4C. The radially distributed fluorescence intensity was extracted (Figure 4.7B) 
and the intensity from the peak location  5 m was averaged to obtain the surface 
concentration in the accumulation zone with the temperature gradient. For comparison, 
the dynamic change of the surface fluorescence was also measured in microchambers 
without a temperature gradient. As shown in Figure 4.7C, the measured surface 
concentration (dots) well matches the simulated kinetics (lines). Initially, temperature 
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gradients generate higher surface binding in the accumulation zone than homogeneous 
temperature. The surface concentration in the laser heated chambers plateaus within 25 
min, while the reaction under a homogeneous temperature continues and diminishes the 
difference between the two groups. This is consistent with the COMSOL simulation of 
reactions in a 50 µm tall microwell where the reaction half-life is reduced by half but the 
maximum surface binding is only enhanced 4% at the steady state (Figure 4.4).  
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Figure 4.7: Experimental measurements of surface binding with a temperature gradient 
or under a homogenous temperature. (A) A typical fluorescence intensity image 10 min 
after the reaction on the microwell floor when  T is present. (B) Radially averaged 
fluorescence intensity profile of Figure 4.7A. The average fluorescence intensity from the 
accumulation zone (peak location  5 m, e.g. between the two circles in Figure 4.7A) 
was used to calculate maximum surface concentration. (C) Kinetics of peak surface 
concentration with (black dot) and without (empty triangle) temperature gradients. In the 
presence of a temperature gradient, the fluorescence intensity in the accumulation zone 
was averaged every 5 min from 3-5 different samples, and the error bars represent one 
standard deviation (n≥3). The solid line is from simulated reactions with a temperature 
gradient and dash line from simulated reactions with a uniform temperature. The 
experimental results are in good agreement with the prediction from COMSOL 
simulation. Statistically different data points in reactions with and without temperature 
gradients are labeled with “*” (𝑝 < 0.05 by two-tailed student t test).   
While a mild temperature gradient has been shown to create non-uniform bulk 
accumulation, 208,210 we demonstrate here that both the binding kinetics and surface 
concentration can also be enhanced by the temperature gradient. Although the 
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improvement of steady-state surface binding appears only moderate using the fast 
NeutrAvidin and biotin interaction, combining a temperature gradient with a patterned 
affinity substrate is expected to limit analyte depletion out of the affinity region and 
promote much elevated local binding on a timely fashion. This is especially appealing for 
micro- and nanosensors where diffusive transport of analyte to a miniaturized binding 
area can be unrealistically long in a dilute solution.201,226 As a moderate temperature 
gradient is biocompatible and can be superposed on a microchamber, it has the potential 
to be integrated with micro- and nanosensors without added complexity to the sensors 
themselves. It is also highly plausible to array the heating source for microarray 
applications.  
Conclusions 
In conclusion, introducing a mild temperature gradient to a microwell reactor enhances 
mass transport and promotes surface binding. COMSOL simulation and dimensional 
analysis show that the enhanced transport is due to combined effects of thermophoresis 
and natural advection, and the relative contribution of each process is dependent on the 
microwell dimension. The benefits to the binding kinetics increases with the 
microchamber height. The steady state surface binding is non-uniform in the presence of 
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the temperature gradient, and the accumulation is more obvious for slow reactions. The 
simulation prediction is confirmed experimentally with one selected microwell geometry. 
The strategy to enhance surface binding through a temperature gradient can be applied to 
improve the sensitivity and time response of biosensors and microarrays.  
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Chapter 5 
Concluding Remarks and Future Outlooks 
5.1 Concluding Remarks 
This dissertation delivers solutions to in vitro isolation, culture, differentiation of cells and 
biomolecule detection in microfluidics. It improves state-of-the-art understanding of 
microfluidic systems in 1) utilizing nanotography for cell isolation using flatbed 
immunoaffinity devices; 2) maintaining and controllably differentiating stem cells; and 3) 
employing a mild temperature to enhance immunoaffinity detection of cell secretion 
molecules.  
 
In Chapter 2, it was demonstrated cell isolation in microfluidics can be achieved and 
further enhanced by systematically studying the relationship between capture efficiency 
and surface roughness using carefully controlled surface nanotopography with the Jurkat 
cells as a model system. The conditions to significantly enhance immunoaffinity cell 
capture under continuous flow were identified. The potential mechanisms of the non-
monotonic relationships between the capture efficiency and surface roughness were 
examined. This work will enable more rational design of cell capture devices. 
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In Chapter 3, it was demonstrated stem cells can be successfully maintained and differentiated in 
a controllable manner in microfluidics using the neural stem cell line C17.2 as a model system. 
The optimum conditions including substrate chemistry and flow conditions to maintain 
C17.2 NSC culture in microfluids has been determined by short term culture. Long term 
culture revealed that neural differentiation of C17.2 NSCs was not influenced by shear 
stress generated by feeding in microfluidics, but was influenced by the nutrient depletion 
level. A medium factor (MF) was used to characterize the relationship between neural 
differentiation and the amount of medium available to cells over time. The findings in 
this chapter offer guidelines to microfluidic system design.   
In Chapter 4, enhancing the detection of molecules secreted by cells has been successfully 
achieved using the biotin-avidin pair as a model system. Introducing a mild temperature 
gradient to a microwell reactor enhances mass transpot to facilitate reactions that are 
often limited by diffusion. The enhanced mass transport coming from a mild temperature 
gradient that induced thermophoresis and convection was demonstrated by COMSOL 
simulation, dimensional analysis and verified by experiments in 50 µm tall microwells 
with and without temperature gradient. The findings in this chapter will enable better 
design of microwell reaction chambers. The temperature gradient could potentially be 
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paired with other additional microfluidic features to further enhance the device’s 
performance.   
With the work in this dissertation, it has been demonstrated that an in vitro microfluidic 
cell analysis system can be developed with the patient’s body fluids as input and the 
patient’s health information as output. Research of important functions of the system 
including isolating cells of interest from patent’s sample, maintaining the sample, further 
inducing differentiation of the cell sample and molecular analysis of the sample has been 
carried out. All functions have been successfully achieved and optimized in 
microfluidics. It is hoped with research in this dissertation, an easy, portable, low cost 
POC (point of care) microfluidic system can be developed and made available to people 
in need.  
5.2 Future Outlooks 
Further integration and automation. Current microfluidic systems often involve off-chip 
sample preparation and/or analysis. Through further integration and automation of 
microfluidics involved in each step, one would hope to obtain one system capable of 
taking patient samples, isolating target cells of interest, preparing cells for analysis and 
performing DNA or molecular analysis. This would save time, reduce the risk of sample 
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loss or contamination, eliminate the need for bulky expensive equipment and 
significantly reduce the need for trained professionals to operate the device and enable 
microfluidics to be commercialized as potentially OTC (over-the-counter) products. 
Bridging the gap between microfluidics and current research tools. Microfluidics, as the 
emerging technology, has found itself highly compatible with certain existing research 
tools such as SPR (surface plasmon resonance), time of flight imaging and AFM (atomic 
force microscopy) that benefit from small scales and a better controlled 
microenvironment. More research tools that have been developed for traditional larger 
scale studies, such as fluorescence microscopy, ELISA (enzyme-linked immunosorbent 
assay and flow cytometry, do not often match with microfluidic systems. Effort to adapt 
these technologies would further empower and offer more variety in microfluidics.  
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